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“Darwin wasn't just provocative in saying that we descend from the apes - he 
didn't go far enough. We are apes in every way, from our long arms and tailless 
bodies to our habits and temperament.” 
 






















Although the human brain has been studied over past decades at 
morphological and histological levels, much remains unknown about its 
molecular and genetic mechanisms.  
Furthermore, when compared with our closest relative the chimpanzee, 
the human brain strikingly shows great morphological changes that have 
been often associated with our cognitive specializations and skills.  
Nevertheless, such drastic changes in the human brain may have arisen 
not only through morphological changes but also through changes in the 
expression levels of genes and transcripts.   
Gene regulatory networks are complex and large-scale sets of protein 
interactions that play a fundamental role at the core of cellular and tissue 
functions. Among the most important players of such regulatory networks 
are transcription factors (TFs) and the transcriptional circuitries in which 
TFs are the central nodes. 
Over past decades, several studies have focused on the functional 
characterization of brain-specific TFs, highlighting their pathways, 
interactions, and target genes implicated in brain development and often 
disorders. However, one of the main limitations of such studies is the data 
collection which is generally based on an individual experiment using a 
single TF. 
To understand how TFs might contribute to such human-specific cognitive 
abilities, it is necessary to integrate the TFs into a system level network to 
emphasize their potential pathways and circuitry.  
This thesis proceeds with a novel systems biology approach to infer the 
evolution of these networks. Using human, chimpanzee, and rhesus 
macaque, we spanned circa 35 million years of evolution to infer ancestral 
TF networks and the TF-TF interactions that are conserved or shared in 
important brain regions.  
Additionally, we developed a novel method to integrate multiple TF 
networks derived from human frontal lobe next-generation sequencing 
data into a high confidence consensus network. In this study, we also 
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integrated a manually curated list of TFs important for brain function and 
disorders. Interestingly, such “Brain-TFs” are important hubs of the 
consensus network, emphasizing their biological role in TF circuitry in the 
human frontal lobe. 
This thesis describes two major studies in which DNA microarray and 
RNA-sequencing (RNA-seq) datasets have been mined, directing the TFs 
and their potential target genes into co-expression networks in human and 
non-human primate brain genome-wide expression datasets.  
In a third study we functionally characterized ZEB2, a TF implicated in 
brain development and linked with Mowat-Wilson syndrome, using human, 
chimpanzee, and orangutan cell lines. This work introduces not only an 
accurate analysis of ZEB2 targets, but also an analysis of the evolution of 
ZEB2 binding sites and the regulatory network controlled by ZEB2 in great 
apes, spanning circa 16 million years of evolution.  
In summary, those studies demonstrated the critical role of TFs on the 
gene regulatory networks of human frontal lobe evolution and functions, 
emphasizing the potential relationships between TF circuitries and such 
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The human brain is complex organ defined by billions of cells that actively 
interacts to control functions, cognitive skills, and behaviors. Gene 
regulatory mechanisms have been hypothesized to be an essential 
mechanism that regulates such brain complexity and functions. In those 
regulatory mechanisms, transcription factors (TF) have a key role to define 
the cell type identity, controlling the expression of the genes and the 
regulatory mechanism architectures. 
To increase the knowledge about TFs, I have explored the TF circuitries in 
human brain from both a brain function and evolutionary perspective using 
genomic approaches.  
In this first chapter, I will introduce the evolution of the brain in primates 
and the potential role of the transcription factors in the human cognition 
and brain disorder.  
This chapter further introduces some aspects of the transcription factors 
functions and what has been uncovered. It describes how microarray and 
RNA-sequencing platforms have been remarkable tools to infer the human 
brain evolution. Finally, an overview of the co-expression network method 
and its application to mine the data presented.  
 
1.1 The primate brain: anatomical evolution   
What makes humans different from the other hominids and great apes? 
This is one of the most intriguing questions that in past decades have 
driven several studies, projects, and scientific fields. In the field of 
paleoanthropology, it is well described how humans belong to the primate 
order, and, since Darwin and his “The Descent of Man, and Selection in 
Relation to Sex”, there has been a continuous effort to better understand 
the evolution of humans.  
The recent discovery of hominid fossils, such as Homo neanderthalensis 
and Denisovan, contribute to a better understanding of the history of our 
species and of the characters and traits which seem human-specific. 
Introduction 
2  
Although our notions about human anatomy and paleoneurology come 
from fossil records, most of the phenotypical changes that happened in 
the human lineage are yet uncharacterized.  
Humans in general can be distinguished by several important traits. For 
example humans are bipedal and their locomotion is significantly different 
when compared with other great apes (Spoor et al. 1994). Humans also 
have smaller canine teeth due to the drastic changes in their diet during 
their evolution (Teaford and Ungar 2000; Dean et al. 2001). 
But one important phenotype that drastically changed in the human 
lineage is a bigger brain that is linked with some human-specific traits 
such as language, tool making, and distinctive sociality (Gibson et al. 
1994; Bickerton 1995; Noble 1996; Adolphs 1999; Schoenemann 2006; 
Pinker 2010). 
Focusing on the brain, there are 350 primate species (Groves 2001) 
featuring a large range of brain sizes, going from 2 grams up to 1.5 
kilograms. Moreover, primates are characterized by an increased 
encephalization (ratio of brain size and body mass) which has remarkably 
reached the highest value in the human lineage (Shultz and Dunbar 
2010). Furthermore, humans have an even bigger cranial capacity relative 
to body size compared with the typical trend of other primates (Hofman 
1983), highlighting how strikingly different the human brain is. This rapid 
enlargement of the brain in primates, and in particular in the human 
lineage, has been associated with cognitive abilities and complex sociality 
(Dunbar and Shultz 2007), and humans in fact show specific traits that are 
presumably linked with the bigger brain.  
For instance, when compared with our closest relatives, chimpanzees and 
bonobos, the human brain is approximately 2 times larger (Carroll 2003), 
and the neocortex, which corresponds to 80% of the total human brain, is 
overdeveloped with a higher number of neurons and glial cells (Herculano-
Houzel 2009), and it is directly linked with cognitive abilities and 





Figure 1.1: Representation of selected primate brain highlighting 
differences in volume and cortical topography. Examples: human (Homo 
sapiens, 1.176 kg), chimpanzee (Pan troglodytes, 273 g), baboon (Papio 
cynocephalus, 151 g), mandrill (Mandrillus sphinx, 123 g), macaque 
(Macaca tonkeana, 110 g). Scale: 5 cm. Figure adjusted (DeFelipe 2011). 
 
Moreover, the primate cortex has shown a higher specialization, with 
“areas” that have specific functions and are linked with specific behavioral 
traits or capabilities. This is common in primates and recent efforts have 
been made to compare these areas between humans and other non-
human primates. For instance, Orban et al. compared homologous visual 
areas between human and rhesus macaque and showed that some areas 
are similar while others are human specific, suggesting again a functional 
evolution of cortical areas in the human lineage (Orban et al. 2004). 
Another interesting example derives from neuroimaging comparisons of 
primate brains. Rilling et al. analyzed primate brains to highlight regions 
that are increased in connectivity in humans, but they also indicate that 
some asymmetries thought to be related to human uniqueness, such as 
language, are actually present also in other great apes (Rilling et al. 2008; 
Rilling 2014).   
From recent efforts, it has been possible to associate distinct cognitive 
and sensory functions to specific areas of the brain, and in particular the 
prefrontal cortex (PFC) seems to be a central region of human-specific 
traits such as planning, personality, behavior, sociality, and language.  For 
several years, the anatomy of the PFC has been thought to be 
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disproportionately larger in humans, but recently it has been proven to be 
the expected size according to the great ape lineage (Semendeferi et al. 
2002).  
These data support the idea that a pure anatomical and morphological 
comparison cannot itself highlight specific traits such as language and 
cognitive abilities, supporting the hypothesis that molecular mechanisms 
such gene expression might be linked with the evolution of human-specific 
traits (King and Wilson 1975). 
1.2 The primate brain: molecular evolution   
With the recent advent of next-generation sequencing, it has been 
possible to better evaluate the human genome and its regulation. 
Moreover, several primate genomes have been completely sequenced, 
giving us the chance to compare genomes, gene expression, and 
epigenetic mechanisms that differ between our species and the other non-
human primates. 
This important step not only helps us to understand the molecular basis of 
specific traits, but further helps us to reconstruct the genomic history of 
humans and the other primates through time.  
Thus we can potentially answer the main questions about this rapid 
neocortical enlargement in humans: What exactly makes us human? What 
genetic mechanisms led to cognitive specialization in humans? 
Starting from sequence differences, Pollard et al. identified several 
genomic sequences rapidly changed in the human lineage (human 
accelerated regions, HARs) that have been implicated in neuronal 
development and patterning, suggesting that those regions might be 
involved in neocortical function and human-specific traits (Pollard et al. 
2006). At the sequence level, other candidates have been discovered for 
human-specific trait evolution and many of them are implicated in brain 
development and cognitive function. One of the most interesting 
candidates is a forkhead TF, FOXP2 (forkhead box P2). Point mutations of 
FOXP2 have been linked with a specific syndrome characterized by 
impaired speech development and severe linguistic deficits (Lai et al. 
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2001; Fisher and Scharff 2009), linking this gene with one of the most 
human specific traits: language. Further analysis of FOXP2 has found that 
not only is it involved in speech and language, but it is also positively 
selected in the human lineage (Enard et al. 2002b; Krause et al. 2007) 
(Fig 1.2), and it is important for central nervous system development and 




Figure 1.2: Silent and replacement nucleotide substitutions mapped on a 
phylogeny of primates. Bars represent nucleotide changes. Golden bars 
indicate amino-acid changes (Enard et al. 2002b). 
 
In addition, recent studies have highlighted microcephaly genes that are 
linked not only with autosomal recessive microcephaly but also with 
human selection (Ponting and Jackson 2005; Thornton and Woods 2009). 
In fact, microcephaly genes such as ASPM, MCPH1, CDK5RAP2, and 
CENPJ seem to be under accelerated rates of evolution (Zhang 2003; 
Mekel-Bobrov et al. 2005; Evans et al. 2006; Rimol et al. 2010; 
Montgomery and Mundy 2012), affirming those genes as candidates for 
the genetics of human brain evolution and setting the basis for specific 
cognitive traits.  
Imprinted genes are other recent candidates that have been considered 
important for brain development, human behavior, and 
neurodevelopmental disorders.   
For instance, ZIM2, ZIM3, ZNF264, and KLF14 have been under 
accelerated evolution in the human lineage (Kim et al. 2001; Parker-
Katiraee et al. 2007), suggesting again that some genes might have 
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specific functions in humans. Other imprinted genes such as GRB10 and 
NESP have been implicated in adult behavior and social interactions (Dent 
and Isles 2014; Davies et al. 2015) and others such as UBE3A and 
SNORD116 have been implicated in neurodevelopmental syndromes such 
as Angelman/Prader-Willi syndrome (Wilkinson et al. 2007), suggesting 
that imprinted genes might be important factor for human brain 
specialization and evolution.  
Even though DNA changes are fundamental for downstream changes, the 
human genome differs only by 1-2% compared with the chimpanzee 
genome and this slight nucleotide sequence difference cannot describe 
completely such drastic phenotypical specialization.  
Evolutionary biology has argued that major phenotypic changes between 
humans and chimpanzees involve gene expression differences. To test 
this hypothesis, microarray and RNA-seq studies have been applied to 
different primate tissues to identify genes that are drastically changed in 
expression.  Firstly, a rate of gene expression acceleration has been 
found in human-specific brain regions compared with other non-human 
primates in multiple studies (Enard et al. 2002a; Khaitovich et al. 2006; 
Somel et al. 2009; Somel et al. 2011) suggesting that humans have 
evolved a specific gene expression pattern.  
Moreover, it has been found that this acceleration signal is more 
substantial in the PFC, which is related to cognitive function and several 
human-specific disorders such as autism spectrum disorder (ASD) and 
schizophrenia. 
However, those results have been recently challenged due to the technical 
issues of such technologies. For instance, microarrays are usually 
designed for model species, such as human or mouse. This leads to 
technical artifacts if hybridization is performed between human 
microarrays and for instance chimpanzee mRNA. Moreover, those studies 
were based on post-mortem brain tissues that can lead to mRNA 
degradation, different cell types and different cell-type ratios.  
In fact, it is well-known that the glia/neuron ratio in human PFC is higher 
compared with chimpanzee (Sherwood et al. 2006) and these data 
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suggest that expression analyses of such tissue might be affected simply 
by the different numbers of specific cells. 
Despite technical artifacts and hypotheses that are awaiting future 
directions, it is plausible that gene regulatory mechanisms might have 
evolved to control such specific gene expression patterns and to shape 
human-specific brain structures. Those mechanisms are comprised of 
several trans-regulators such as TFs, RNA binding proteins, non-coding 
RNAs, epigenetics, and chromatin modifiers, giving us the opportunity to 
study not only DNA changes but also the key players that control gene 
regulation. 
1.3 Transcription factors   
Transcriptional regulation is one of the most important processes in the 
gene regulatory mechanisms of a cell. In fact, we can include 
transcriptional regulation in a multi-layer gene regulation program that 
includes chromatin regulation, epigenetic mechanisms, transcriptional 
networks, alternative splicing networks, and translational mechanisms.  
Focusing on the transcriptional network, transcription is generally 
described as the mechanism to convert the genetic information of DNA 
into RNA. It involves several proteins that can be grouped into two main 
categories: the basal machinery proteins that include RNA polymerase 
and general TFs, and the specific machinery proteins that include specific 
TFs which regulate the initiation of transcription, activating or repressing 
the expression of target genes.  
The basal machinery combines the action of RNA polymerases and the 
basal TFs. RNA polymerases are involved in the transcription of rRNA 
(RNA pol I), mRNA and microRNA (RNA pol II), and tRNA (RNA pol III). 
The basal TFs allow the positioning of RNA polymerases onto the 
transcription start sites (TSSs) of genes. The mediator complex bridges 
the action of specific TFs with the basal machinery complex. 
The specific machinery instead involves the specific TFs, which play a role 
in activating or repressing the expression of their target genes. The 
specific TFs bind specific DNA sequences, such as cis-regulatory 
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elements of circa 6-10 nucleotides, in the flank region of their target genes 
defined as the promoter region. They affect specifically the expression of 
their targets in a tissue-specific manner or in response to particular stimuli, 
activating or repressing mRNA levels. They are also involved in chromatin 
remodeling, splicing and differential transcript expression.  
  
 
Figure 1.3: Representation of the transcriptional machinery with basal 
TFs, RNA polymerases, mediator complex and specific TFs (Boyle lab, 
web source).  
 
 
1.4 Gene regulation played by transcription 
factors  
In past decades gene expression has been one of the most interesting 
fields in research. This complex process involves multiple aspects such as 
the TF machinery above mentioned, chromatin remodeling, alternative 
splicing events, ncRNAs, copy number variants, and translational 
mechanisms.   
TFs interact with DNA in specific regions called transcription factor binding 
sites (TFBS) which are usually 6-10 nucleotides in length. 
Recent efforts have been made to clarify where TFs bind. Genome-wide 
studies have shown that TFs can bind not only in the promoter region of 
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their target genes but also in intronic or exonic regions, suggesting that 
TFs might affect expression at multiple levels (Consortium 2004; Wei et al. 
2006; Stergachis et al. 2013; Ballester et al. 2014).  They can also act 
singularly or cooperatively to enhance or reduce gene expression (Hai and 
Curran 1991; Li et al. 2004; Gorbacheva et al. 2005). 
As mentioned above, gene expression itself might change due to changes 
at the cis-regulatory level. There are basic cis-regulatory elements, such 
as TATA-box elements, that are necessary for the binding of the basal 
TFs and are present in all the TSSs of coding genes. Instead, the specific 
cis-regulatory elements are necessary for the specific TFs and are usually 
present in the promoter regions. 
Some cis-regulatory elements, such as E-Box elements, might be shared 
between TFsand therefore specific TFs might have common target genes. 
They can be separated into enhancer or silencer elements according to 
the activation or repression role of the specific TFs that can bind the 
elements. Another type of element usually present near enhancer or 
silencer elements is the insulator element. This element plays a role in 
gene expression regulation by blocking transcription when specific TFs 
are bound here. TF activity can be modulated by various factors. Histone 
modifications, such as acetylation or methylation, play an important role in 
the accessibility of TFBSs for the specific TFs and co-factors (Villar et al. 
2015). DNA methylation is another important TF activity regulator that 
converts cytosine into methyl-cytosine, preventing the binding of TFs and 
therefore preventing the upstream regulation of specific target genes 
(Eden and Cedar 1994; Jones and Takai 2001). 
Another important aspect of TFs is their cooperation. In fact, TFs are 
known to interact to regulate the expression pattern of a gene. To do so, 
TFBSs are usually clustered in modules called cis-regulatory modules. 
This allows multiple TFs to activate or repress specific genes based on the 
cell or tissue activity. Example of TF interactions are CLOCK and BAML1 
complex that modulate circadian rhythms and activity (Gekakis et al. 1998; 
Gorbacheva et al. 2005; Ko and Takahashi 2006). Other examples are the 
functional interaction between FOXP1/2/4 that are implicated in multiple 
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brain specific functions and disorders, such as speech or intellectual 
disability (Li et al. 2004; Hamdan et al. 2010; Bacon and Rappold 2012). 
In summary, TFs and their activity depend on complex regulatory 
networks composed of TFBS affinities, TF interactions, TFBS modules, 
DNA methylation, and chromatin states.   
1.5 Transcription factors in human   
A common way to classify TFs is based on their structural DNA binding 
domains. This has been helpful for understanding how TFs can recognize 
DNA motifs, what the potential functions of the TFs are, and what their 
evolutionary histories are. 
A recent overview of TFs has helped to catalogue them according to what 
was previously known and includes a census of human TFs (Matys et al. 
2003; Vaquerizas et al. 2009; Chawla et al. 2013). 
The TFs are categorized according to their binding domain (TFDBD) as:  
• Basic leucin zipper (bZIP) 
• Zinc finger (ZNF) 
• Homeodomain 
• Helix-loop-helix (HLH) 
• Other domains (es. Forkhead) 
 
In total, we can group the TFs into 54 structural families and distinguish 
circa 15 specific DNA-binding domains. The ZNF are the most present 






Figure 1.5: Number of TFs according to their TFDBD in human 
(Vaquerizas et al. 2009). 
 
Nevertheless, TFs and their target genes are poorly understood and only 
recently have studies and tools been implemented to cover this lack of 
knowledge. 
For instance, DBD is a database for TF prediction according to the domain 
assigned by SUPERFAMILY or Pfam (Wilson et al. 2008). Jaspar, 
Factorbook, and TRANSFAC are databases that contain a curated 
collection of known TFs in eukaryotes (Matys et al. 2003; Mathelier et al. 
2013; Wang et al. 2013b). ChEA is a novel tool with an inference of TF 
regulation integrating genome-wide chromatin immunoprecipitation (ChIP) 
experiments such as ChIP-chip and ChIP-seq (Lachmann et al. 2010). 
MEME, XXmotifs, and HOMER are suites for motif discovery, comparing 
motifs, and finding specific motif enrichment (Bailey et al. 2009; Heinz et 
al. 2010; Luehr et al. 2012).  
However, most of the TF studies are based on single experiments, usually 
ChIP-seq, targeting a cell-type or eventually a tissue. This bottleneck is 
one of the major limitations of TF studies, since their regulatory activity 
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depends on different cell states, such as chromatin architecture or 
epigenetic mechanisms, which can drastically alter the TF circuitry. 
Moreover, we still lack understanding of the complete picture of the TF 
circuitries that regulate development, evolution, and disorders of specific 
tissues. 
Therefore studies at the gene regulatory network level are necessary to 
fully understand and predict such TF circuitries in different tissues and 
how they might be implicated in the evolution of specific tissues or skills. 
A network approach that has been recently developed is the co-
expression network which uses expression correlations to infer common 
pathways or potential TF target genes. 
1.6 Transcription factors and brain development   
Due to the key role of the TFs in the human brain regulatory mechanisms, 
we can rephrase the main question in the previous chapter as: “Which TFs 
make us human?” 
To this end, recent efforts have been directed to understand the complex 
mechanisms that regulate brain development and also the associated 
functions. In fact, the brain, especially the neocortex, plays a central role 
in cognition, sensory and associative functions, and motor activities. 
However many of the molecular mechanisms that control those functions 
and structures remain undiscovered.  
The transcriptional circuitry has been highlighted as the core of the gene 
regulatory mechanisms that might be implicated in shaping and controlling 
brain function and development (Somel et al. 2014; Nord et al. 2015). 
High-throughput sequencing methods such as ChIP-seq and RNA-seq 
and animal models such as tissue-specific knock-out mice have helped 
researchers uncover and functionally characterize several TFs in a cell- or 
tissue-specific way. 
For instance, the MEF2 family (A-D) has been widely characterized on a 
brain-function level, with high expression during brain development (Leifer 
et al. 1994; Flavell et al. 2008; Lyons et al. 2012). MEF2 proteins have 
been implicated in several neuronal functions such as differentiation, 
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migration, and synaptic activity (Lin et al. 1996; Flavell et al. 2008; Chan et 
al. 2015), and in particular MEF2C has recently been implicated in ASD 
and schizophrenia etiologies, highlighting the role of such TFs in brain 
function and development (Fig 1.6a). 
 
 
Figure 1.6a: Characterization of MEF2C cKO RNA-Seq differentially 
expressed genes. (A) Heatmap showing the disorder-related genes 
differentially expressed in MEF2C cKO (KO) compared with wild-type 
(WT). In light red, genes with higher expression; in light blue, genes with 
lower expression. (B) Gene ontology enrichment for MEF2C cKO 
differentially expressed genes. In light red, the up regulated genes; in light 
blue, the down regulated genes. Circle size is correlated with the adjusted 
p-value. Gene ontology categories are alphabetically listed on the y axis. 
Differentially expressed genes showed enrichment for categories involved 
on neuronal development and synaptic transmission. (C) Venn diagram 
showing the overlap between MEF2C cKO differentially expressed genes 
and gene sets of interest. Marked, the overlap p-values. (Hypergeometric 
test, perm = 0.001). Genes for each gene sets are indicated. (D) 




Additionally, FOXP2 is an important TF implicated in CNS development 
and human-specific cognitive functions such as language (Enard et al. 
2002b; Fisher and Scharff 2009; Konopka et al. 2009). Human FOXP2 
differs from chimpanzee FOXP2 by two amino acids. These protein-level 
differences have been shown to affect gene regulation in neuron-like cells, 
highlighting genes important for brain development and function and 
supporting the idea that protein changes in TFs have a biological effect on 
downstream targets (Fig 1.6b) (Konopka et al. 2009).  
 
 
Figure 1.6b: Module of genes differentially expressed by human-
chimpanzee FOXP2. Hub genes highlighted by node dimension. Genes 
differentially expressed are hub of this module.   
 
FOXP1, a paralog of FOXP2, has also been recently implicated in 
neurodevelopmental disorders such as intellectual disability, ASD, and 
language impairment (Hamdan et al. 2010; Bacon and Rappold 2012; 
Lozano et al. 2015). Multiple studies have shown that FOXP1 complete 
and partial deletions in regions implicated in mouse vocalization and 
behavior are associated with several cognitive and social deficits, 
underlining the behavioral implications of FOXP1 transcriptional control  
(Bacon et al. 2015). 
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Another example is CLOCK, a circadian rhythm gene implicated in bipolar 
disorder (Benedetti et al. 2003; Benedetti et al. 2007), which has been 
found in a human frontal pole-specific module when compared with other 
non-human primates, suggesting a specific role for this important TF in 
regions implicated in human-specific behavioral phenotypes (Fig 1.6c) 
(Konopka et al. 2012). 
 
 
Figure 1.6c: Human specific frontal pole co-expression module. (A, B) 
Network visualization of the human specific module shows CLOCK as 
hub gene. (C–F) Immunohistochemistry for CLOCK in human FP (C) and 
chimpanzee FP (E). Corresponding negative control sections are shown 
in (D) and (F). Scale bars represent 100 µm (Konopka et al. 2012). 
 
However, despite the importance of several TFs in the brain, the 
complexity of their regulatory mechanisms is still largely unclear. In fact, 
one limitation is that most of the characterized TFs are traditionally 
analyzed singularly in a specific cell-type or tissue. Recent efforts have 
been made to analyze multiple TFs by ChIP-seq or different techniques 
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deriving transcriptional regulatory networks from a small number of 
different TFs (Schmidt et al. 2010; Jolma et al. 2013; Ballester et al. 2014) 
and inferring the regulatory interactions using the TF binding sites or their 
expression  (Shalgi et al. 2007; Nowick et al. 2009; Neph et al. 2012). 
Nevertheless, understanding the TF regulatory networks in specific cell-
types or tissues is still in its infancy. 
1.7 Transcription factors and networks   
With the advent of transcriptomic methods, it has been possible to 
uncover molecular systems and gene regulatory networks on a large 
scale. Moreover, it has been possible to relate such system-level methods 
to development, behavior, health, and disorders such as ASD, intellectual 
disability or schizophrenia. 
Network helps us to visualize the cellular or tissue gene expression state 
on a higher biological level. In such systems, the nodes correspond to 
genes of interest while the edges correspond to the relationships between 
them. Importantly, edges might be defined as physical interactions (PPi 
network), inferred by probability (Bayesian network), or inferred by co-
expression and weights (co-expression network and weighted co-
expression network). 
In particular, the co-expression network is one of the network approaches 
that enable the combination of genome-wide expression profiles into a 






Figure 1.7a: Example of co-expression networks. Node size corresponds 
to the number of links (e.g Hub genes) and their genetic association.  
 
The co-expression network is based on gene expression correlations and 
helps to evaluate potential interactions that might be relevant for the 
regulatory mechanisms of an examined tissue.  
Gene co-expression network analyses have been widely used in several 
biomedical branches such as cancer biology (Jia et al. 2014; Liu et al. 
2015), evolutionary biology (Oldham et al. 2006; Nowick et al. 2009; 
Konopka et al. 2012; Xu et al. 2015) and neuroscience (Winden et al. 
2009; Voineagu et al. 2011; Ben-David and Shifman 2012; Parikshak et al. 
2013; Willsey et al. 2013). This method allows researchers to infer novel 
protein-protein interactions, predict gene functions, or predict potential 
candidates for a disorder. Additionally, an increased effort has been made 
to develop new tools for gene module identification or network functional 
enrichment uncovering new pathways and functions. 
As previously mentioned, gene expression is the basis of the co-
expression network and gene expression can vary among cells, tissues, 
and individuals of the same species, individuals of different species, and 
individuals affected by a disease compared with healthy individuals.   
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Therefore gene expression correlations can drastically change between 
different conditions and might reflect a disruption at the regulatory system 
level that might be potentially linked with the analyzed case. 
The correlation can vary between Pearson correlation coefficient, 
Spearman rho coefficient, Kendall’s tau correlation, or biweight 
midcorrelation. These parameters defined the interactions according to the 
expression between two or multiple genes. However, single gene to gene 
correlation might contain several false positives, decreasing the quality of 
the interpretation assessment.  To avoid the effect of false positive 
interactions, an additional method has been developed to increase the 
strength of the co-expression approach.  
The weighted co-expression method described the correlation patters 
among two or multiple genes. In such networks, the nodes represent 
genes whereas the links represent the weight calculated using the 
correlation of the overlapped genes. 
A previously established method, called weighted topological overlap 
method (wTO), is remarkably suitable for TFs and other regulatory 
proteins (Nowick et al. 2009). Instead of drawing all the correlated genes, 
the wTO method allows the visualization of TF interactions by weighting in 
a single link the correlation between the TFs and the TF-associated gene 
sets (Figure 1.7b).  
 
 
Figure 1.7b: Example of TF co-expression network (Nowick et al. 2009). 
In red, upregulated TFs in human frontal cortex compared with 
chimpanzee; in green, downregulated TF in human frontal cortex 
compared with chimpanzee. Edges represent the wTO values between 




Furthermore the wTO method uses the Spearman rank correlation, which 
is suitable for expression analysis, and the weight is based on both 
positive or negative correlation. In fact TFs can act as activators or 
repressors of gene expression and therefore the correlation might reflect 
the biological function of a TF. A gene that is negatively correlated with a 
TF reflects an opposite expression trend and thus the TF might be a 
potential repressor of this gene. On the other hand, a gene that is 
positively correlated with a TF reflects a similar expression trend and thus 
the TF might be a potential activator of this gene.   
As previously suggested, this method focuses on TFs and their potential 
target genes, mining the potential pathways in which the TFs might be 
involved. Remarkably, the wTO method is the most suitable approach to 





How TFs regulate the expression of multiple genes at the tissue or cell 
level is largely unexplored. Moreover, even less is understood about gene 
regulation when comparing different species, such as human and non-
human primates.  
TFs have a central position in gene regulatory networks due to their key 
role in the regulation of gene expression and it seems plausible that TFs 
are also important for brain function and related neurodevelopmental or 
neuropsychiatric disorders. 
This thesis is organized in three major chapters spanning from the 
evolution to the functional characterization of a specific TF: 
 
The first chapter describes a co-expression approach to understanding 
how a TF co-expression network evolves. In particular, we analyzed 
genome-wide expression profiles of the frontal cortex from different 
primate species including human, chimpanzee, and rhesus macaque 
spanning circa 35 million years of evolution. We first examined potential 
candidate TFs with differential expression and we next applied a novel 
network approach based on inter-species and intra-species correlation 
filtering, followed by wTO calculation to infer how the network evolved. We 
moreover analyzed different tissues highlighting a drastic rewiring of brain 
TF networks compared with other tissues such as kidney and muscle. 
Taken together, these data emphasize the role of TFs in human-specific 
brain evolution, development and function.  
 
The second chapter describes an approach to evaluate multiple genome-
wide expression profiles from human PFC. Due to stochastic gene 
expression and technical artifacts, we developed a novel approach to 
integrate multiple expression datasets into a consensus network, 
highlighting only the conserved edges between TFs. We next manually 
collected from different sources TFs with known implications on brain 
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function and disorders, giving us the opportunity to create the first list of 
“Brain-TFs”. With this novel method and the census of Brain-TFs, we 
identified a strong enrichment of such important TFs in the consensus 
network. Moreover, we also identified by connectivity novel and well-
characterized TFs (i.e. hub genes) that might be drastically important for 
the regulation of gene expression in human frontal cortex, a brain region 
implicated in cognitive function and disorders.  
 
The third chapter describes a functional characterization and evolution of 
the TF ZEB2 by ChIP-seq and RNA-seq in different great-apes species. 
ZEB2 is an important hub gene in a TF co-expression network specifically 
upregulated in human PFC compared with chimpanzee PFC. 
Furthermore, mutations in the ZEB2 protein have been linked with Mowat-
Wilson syndrome, a severe disorder characterized by intellectual disability 
and acute microcephaly, suggesting ZEB2 as an important candidate for 
human-specific cognitive functions. However, little is known about the 
targets and the species-specific features of ZEB2. Therefore we aimed to 
functionally characterize ZEB2 in different human individuals and 
understand whether ZEB2 binding sites have undergone evolutionary 
pressure during great-apes evolution.  
We used 3 different immortalized lymphoblastoid and fibroblast cell-lines 
from each human, chimpanzee, and orangutan spanning circa 16 million 
years of great-apes evolution. We performed ChIP-seq and ZEB2 
knockdown followed by RNA-seq to evaluate the species-specific 
transcriptional control played by ZEB2. We found several species-specific 
and shared ZEB2-bound regions. Combined with the analysis of 
differential gene expression using RNA-seq after ZEB2 knock-down, we 
have been able to functionally characterize ZEB2 in different great-apes 
species and highlight the several candidates implicated in brain function 




































CHAPTER 1  
Species-specific changes in a primate transcription 
factor network: insights into the molecular 
evolution of the primate prefrontal cortex. 
 
Project summary 
The human prefrontal cortex (PFC) differs from that of other primates with 
respect to size, histology, and functional abilities. Here we discovered 
evolutionary changes in a transcription factor (TF) network that may 
underlie these phenotypic differences. We determined the co-expression 
networks of changed TFs including their potential target genes and 
interaction partners in the PFC of humans, chimpanzees, and rhesus 
macaques using genome wide expression data. Integrating the networks 
of all three species allowed us inferring an ancestral network for all three 
species, as well as for humans and chimpanzees. All networks are 
enriched for genes involved in forebrain development, axonogenesis, and 
synaptic transmission. Interestingly, however, we detected strong network 
rewiring during primate evolution, with most links gained on the human 
lineage. By comparing the network of the PFC to networks derived from 
other tissues, we discovered that the human PFC has the most 
evolutionary changes. To pinpoint molecular changes underlying species-
specific phenotypes, we analyzed the sub-networks of TFs derived only 
from genes with species-specific expression. These sub-networks differed 
significantly in structure and function between the human and chimpanzee. 
For example, the human specific sub-network is enriched for TFs 
implicated in cognitive disorders and for genes involved synaptic plasticity 
and functions. Our results suggest evolutionary changes in TF networks 
that might have shaped morphological and functional differences between 




Understanding why humans have unique cognitive abilities requires the 
identification of morphological and molecular aspects that are unique to 
the human brain. Unique morphological features of the human brain 
include its larger size (Povinelli and Preuss 1995; Koechlin et al. 2003; 
Schoenemann 2006; Enard 2015), its cell type compositions (Sherwood et 
al. 2006; Oberheim et al. 2009; Spocter et al. 2012), and specific cortical 
architectural structures (Buxhoeveden et al. 2006; Smaers et al. 2011). At 
the molecular level, there are several genes with brain functions that have 
been shown to evolve under positive selection on the human lineage, 
making them prime candidates for having contributed to the evolution of 
human specific features;  for example ASPM (Zhang 2003; Mekel-Bobrov 
et al. 2005; Montgomery and Mundy 2012) and MCPH1 (Ponting and 
Jackson 2005; Voight et al. 2006; Pulvers et al. 2015), which determine 
brain size, and FOXP2, which when mutated causes severe cognitive and 
speech deficits (Enard et al. 2002b; Fisher and Scharff 2009; Konopka et 
al. 2009). Moreover, evolutionary young KRAB zinc-fingers (ZNFs) genes 
have been shown to be preferentially expressed in the human developing 
PFC (Zhang et al. 2009) and to evolve rapidly in sequence and expression 
in primates (Looman et al. 2002; Nowick et al. 2009; Nowick et al. 2010; 
Nowick et al. 2011), suggesting that this gene family has played an 
important role during the evolution of the human brain. In line with these 
findings, several studies identified expression differences in the human 
compared with the chimpanzee brain that might be linked to human 
specific traits (Enard et al. 2002a; Cáceres et al. 2003; Somel et al. 2009; 
Babbitt et al. 2010; Liu et al. 2012). Since expression changes are often 
controlled by TFs that are enhancing or reducing the expression of target 
genes it seems likely that TFs are responsible for driving some of the 
expression pattern differences and hence morphological differences 
between humans and other primates. Nevertheless, only a limited number 
of studies so far has focused on evolutionary changes in TFs or TF 
networks in primates (Oldham et al. 2006; Nowick et al. 2009; Schmidt et 
al. 2010; Schwalie et al. 2013; Ballester et al. 2014). These studies were 
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limited in that the network analysis was based on ubiquitously expressed 
genes (i.e. not being able to reveal brain specific differences) and only 
included human and chimpanzee samples (i.e. not being able to 
distinguish between changes on the human or chimpanzee lineage). 
Moreover, while progress in uncovering the biological cascades that take 
place during mammalian brain development has been made, how the 
striking morphological and functional differences of the human brain are 
determined is still not well-understood. To gain more insights into the gene 
regulatory processes that might underlie human specific brain evolution, 
we investigate here how a TF co-expression network evolves in the 
primate PFC. To do so, we analyzed genome-wide expression data from 
PFC samples of humans, chimpanzees and rhesus macaques to first 
determine the genes that are specifically changed in each species. In total, 
we identified 645 genes coding for TFs that show lineage-specific 
expression, among them 134 known to be involved in brain development, 
functions, and/or diseases. We then derived weighted topological overlap 
(wTO) networks from the changed TFs and their correlated genes and 
compare these networks between the three species to infer the ancestral 
network and evolutionary network changes in the human and chimpanzee 
lineages. To further evaluate which evolutionary changes might be specific 
to the brain, we used genome-wide expression data from multiple tissues. 
Remarkably, we identified an increased rewiring in brain tissues compared 
to other tissues, with higher TF network connectivity in the human 
compared to the chimpanzee brain. We further showed that the network of 
the human PFC is enriched for TFs implicated in crucial brain functions 








Lineage-specific expression pattern changes 
To identify species-specific expression patterns we analyzed RNA-Seq 
data (Methods), derived from PFC samples of 5 adult human, chimpanzee, 
and rhesus macaque individuals. Genes were defined as species-
specifically “changed” if their difference in expression was significant 
(Benjamini-Hochberg adjusted p-value < 0.05 and |log2FC| > 0.3) in one 
species compared to the other two species, but not significant between the 
other two species (Methods).  
Due to its distant evolutionary relationship with great apes, we found the 
highest number of specifically changed genes in rhesus macaques. 
However, when we normalized the number of specifically expressed genes 
for divergence time, we found about equal numbers of changes in all three 
lineages, suggesting that overall gene expression changes are similar 
between lineages. Among the genes with species-specific expression we 
found 645 genes coding for TFs, consisting of 103 human specifically 
expressed TFs, 81 chimpanzee specifically expressed TFs, and 462 
rhesus macaque specifically expressed TFs, highlighting a significant 
enrichment of TFs among differentially expressed genes (8%, p-value = 
0.02, Chi Squared Test). Moreover, we validated that a significant 
proportion of significantly changed TFs has also changed in an 
independent genome-wide expression dataset produced with a different 
technique (Somel et al. 2011) (116 total changed TFs, p-value = 1.19x10-
58, hypergeometric test; permutation test, p-value = 0.0001).  
To conjecture potential impacts of the species-specific TF expression 
changes on species differences in brain functions, we first asked how 
many of the changed TFs are known to have a role in the brain. Our 
literature review discovered 134 changed TFs that are described to have a 
function during brain development or are implicated in a brain disease 
(Appendix: Table S1.1).  
This represents an enrichment of TFs with known brain functions among 
the differentially expressed TFs (hypergeometric test; p-value = 1.21x10-55, 
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permutation test, p-value = 0.0001). Remarkably, more than a quarter of 
the human-specifically changed TFs are “Brain-TFs” (27; Fisher exact test, 
p-value = 0.028), a proportion that is larger than for the chimpanzee- and 
rhesus-macaque specifically changed TFs (Chimpanzee, 14; Fisher exact 
test, p-value = 0.62; Rhesus macaque, 93; Fisher exact test, p-value = 
0.15).  
Among these human-specifically changed “Brain-TFs”, are for example  
CLOCK, a circadian regulator involved in multiple disorders such as 
bipolar disorder (Gekakis et al. 1998; Coque et al. 2011; Menet and 
Rosbash 2011), CC2D1A, which is implicated in non-syndromic mental 
retardation (Basel-Vanagaite et al. 2006; Rogaeva et al. 2007), and EGR1, 
a gene implicated in social behavioral of several species (Robinson et al. 
2008) (Fig. 1.1). Our findings thus support earlier suggestions that TFs 
with changed expression in primate brains might have played a crucial role 





Figure 1.1: Expression patterns of human specific “Brain TFs” that are 
known to be involved in brain functions and disorders. 
 
TF networks in each species 
As the function of many of the species-specifically changed TFs is 
currently unknown (Consortium 2004; Mathelier et al. 2013; Wang et al. 
2013b), we analyzed their co-expression patterns to gain more insight into 
the functions of the species-specifically changed TFs and into the potential 
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phenotypic impact of their expression changes. We reasoned that genes 
that are co-expressed with a TF represent potential target genes or 
interaction partners of that TF. Further, TFs with similar sets of co-
expressed genes are likely functionally related. We aimed at capturing the 
co-expression patterns of the changed TFs and their similarities using a 
network approach.  
To this end we utilized a third, independently derived, dataset with a high 
number of samples to allow for confident co-expression analysis (Liu et al. 
2012). We selected from this dataset 12 individuals per each species 
matched by sex and age according to their life traits (Methods). For each 
of the 645 TF genes we identified the genes with correlated expression 
patterns across the individuals of a species (Spearman rank correlation 
test, p-value < 0.05). Since TFs can activate or repress the expression of 
genes, we calculated positive and negative correlations. To analyze the 
overlap in the correlated gene sets between the TFs we calculated the 
weighted topological overlap (wTO) using a method we developed 
previously  that considers both, positive and negative correlations (Nowick 
et al. 2009). This allowed us to construct a wTO network for each species 
in which the nodes represent the 645 expression changed TFs and the 
links the correlations between the TFs including the commonality of the 
TFs in their sets of correlated genes. From a biological perspective, TFs 
that are linked in the wTO network might cooperatively regulate a 
significant set of potential target genes.  
Performing permutation tests in which we shuffled for each individual the 
expression values of all the genes we demonstrated that the derived wTO 
network of each species differs from random expectation independently of 
the employed wTO cutoff (supplementary Methods). Since none of the 
randomized networks displayed links with |wTO| > 0.3, we applied |wTO| > 
0.3 for all further analyses of these human, chimpanzee and rhesus-
macaque PFC networks. Moreover, we found that several of the links we 
inferred had been discovered experimentally earlier, such as the 
interaction between MEF2C and HIRA (Yang et al. 2011), MEF2C and 
HDAC9 (Haberland et al. 2007; Potthoff and Olson 2007), or MYCN and 





Figure 1.2: Methodological workflow for calculating wTO networks.  
(A) A dataset comprising PFC samples of adult individuals per each 
species has been used to identify the species specific differentially 
expressed genes and TFs. (B) We calculated Spearman rank correlations 
for each of the 645 TFs with species specific expression with all expressed 
genes. Correlated genes were filtered according to the criteria shown in 
red in each box, whereby pval stands for the p-value of the correlation and 
rho for the correlation strength, which needed to have the same sign 
(positive or negative) in case of the inferred ancestral networks. We then 
calculated a wTO network from all genes that passed the respective 
filtering criteria for humans, chimpanzees, rhesus macaques, the human-
chimpanzee- and the human-chimpanzee-rhesus macaque-ancestor. A 
comparison of these five networks allowed us to investigate the evolution 
of network links. (C) For the species specific EC subnetworks we only 
considered TFs that were specifically expressed in the respective species. 
Their correlated genes (Spearman rank correlation, p<0.05) were filtered 
for also being species specifically expressed in the same species and for 
displaying an expression change that is in the direction that is in 
agreement with the direction of the expression change of the TF and the 
sign of the correlation to that TF (see text). In red, species specifically 
upregulated TFs and correlated genes; in green, species specifically 
downregulated TFs and correlated genes. The wTO of the species-specific 




To examine how the TF network has evolved, we inferred which links were 
likely to have been present already in the human-chimpanzee (HC) and 
the human-chimpanzee-rhesus macaque (HCR) ancestor (Fig. 1.2). Using 
the rhesus macaque as outgroup, we further determined the network links 
that are likely specific to either the human or chimpanzee network. 
Strikingly, comparing the ancestral and the species-specific networks, 
considerable rewiring is visible. While all three species share only 531 
links (the inferred HCR ancestor) and humans and chimpanzees share 
only 239 links (the inferred network of HC ancestor), the human network 
contains 2238 links that are human specific. Also the chimpanzee and 
rhesus macaque have many species-specific links, namely 1113 and 389 
links, respectively. To confirm that these stark species differences are not 
driven by a few individuals, we performed a “leave-one-out” test 
(Methods). All 12 networks per species derived this way clustered 
according to species, demonstrating that the observed network divergence 
is robust (Appendix: Fig. S1.1). 
The human network has significantly higher connectivity (number of links 
per nodes; c = 13.2; |wTO| > 0.4) than the chimpanzee network (c = 8.1, 
|wTO| > 0.4; Wilcoxon test, p-value = 2.47x10-10) and the rhesus macaque 
network (c = 3.9, |wTO| > 0.4; Wilcoxon test, p-value = 2.2x10-16). Taken 
together, this indicates that the network complexity increased on the 
human lineage. Our data allows us to incrementally follow how the 
network architecture has been rewired during evolution. For example, 
BBX, is a TF that has many links in the two ancestor and in all three 
species specific networks. Fifty three of its links are present in the 
ancestor of all three species. In addition to these links, BBX gained 3-11 
links on the particular lineages (Fig. 1.4 A). CC2D1A on the other hand, 
does not have any links that are conserved between all three species. 
Remarkably CC2D1A gained 91 links gained on the human lineage (Fig. 
1.4 B). This is fascinating given that CC2D1A is a conserved TF which is, 
as mentioned above, associated with intellectual disability in humans 





Figure 1.3: Example of gain and loss genes in primate evolution. (A) BBX 
showed an increase number of links in all the analyzed primates. (B) 
CC2D1A gained species-specific links in human lineage.   
 
Other interesting examples are FOXG1, RAB37, STAT6, ZMAT3, and 
ZNF436, which are hubs in almost all networks, and CDK5, CNBP, HTT, 
MEF2D, PER2, STAT6, and TLE3, which seem to be hubs only in the 
human network.  
To gain insights into the functions fulfilled by the TF networks, we tested 
for enrichment of Gene Ontology (GO) groups among the genes 
correlated with the TFs. For this analysis we ranked all genes based on 
the number of TFs in the network they are correlated with (Methods). In 
each of the five networks (Fig. 1.4), we found that genes with many 
correlations with TFs show an overrepresentation in GO groups related to 
axonogenesis, synaptic transmission, learning and memory, and other 
brain functions. This suggests that, although strong rewiring occurred in 
the TF network of primate PFCs, overall the functions and pathways 






Figure 1.4: Network evolution. In light blue, the human-chimpanzee-
rhesus macaque ancestral network; in purple, the human-chimpanzee 
ancestral network; in green, the rhesus macaque specific network; in red, 
the chimpanzee specific network; in blue, the human specific network. In 
black, we highlighted the lineage specific or conserved hubs. Hubs were 
















Species differences in the networks of other tissues 
Given the strong rewiring we observed in the life-span PFC, we asked 
whether similar extents of rewiring exist also in the adult PFC, in other 
brain areas, and in other tissues. We thus built wTO networks for multiple 
tissues utilizing samples from adult individuals (Bozek et al. 2015). When 
comparing network similarities across species and tissues, there seems to 
be a trend for a clustering according to tissues, with a slight separation 
between brain and non-brain tissues.  
The adult rhesus macaque PFC and CBC are the most distant networks 
with higher connectivity than the adult PFC and CBC of humans and 
chimpanzees (Fig. 1.5 A). In the networks for kidney and muscle we 
observed fewer differences in degree distribution between species than in 
the brain tissues. Similarly to the life-span PFC, the human network of the 
adult visual cortex also displays an excess of links compared to the other 
two species. Interestingly, the wTO networks of human brain tissues 
always had a higher number of links compared to the wTO networks of 
chimpanzee brains, which is not the case in the muscle and kidney 
networks (Fig. 1.5 B and C).  
Comparing the networks between different tissues allowed us to pinpoint 
links and hubs that are specific to the human PFC. Interestingly, among 
the TFs with the most links in the networks of the human adult and life-
span PFC but fewer links in most other networks are three TFs that are 
associated with neurodegenerative disorders in which the motor control is 
constrained (Appendix: Fig. S1.2). 
As seen for the networks derived from the life-span PFC, our GO analysis 
of the adult human PFC network also revealed a strong enrichment for 
categories related to brain functions such as synapse organization, 
learning, and behavior (e.g. locomotory behavior), while such functions 
were much less enriched in the adult chimpanzee and rhesus macaque 




Figure 1.5: Network evolution overview. (A) Multidimensional scaling plot 
representing the distances calculated using the wTO values. In red, the 
PFC; in blue, the CBC; in black, the life-span PFC; in green, the VIS; in 
brown, the KD; in pink, the MSC. Rhesus PFC and CBC has shown a 
drastic rewiring during evolution. (B)  Degree distribution (log2 scaled) of 
all TF-wTO networks. Except for PFC and CBC, human networks have a 
higher number of links compared with the other primates. (C) Wilcoxon 
rank test for the greater enrichment of connectivity compared between 
species. Human showed always a greater connectivity compared with 














Expression Changed Sub-Networks 
While all TFs in the network have changed in expression, it does not mean 
that the genes correlated with these TFs have also changed in expression. 
In fact, many of the lineage-specific changes in network wiring could have 
evolved to compensate for other mutations to keep the expression of the 
associated genes conserved. This notion is supported by our observation 
that the enriched GO groups are the same for the PFC networks of all 
three species. Since the genes with species-specific expression changes 
are most likely to drive phenotypic differences between the three species, 
we determined next which TF correlated genes have species-specifically 
changed in expression.  
We filtered all TF correlated genes requiring that their expression change 
is consistent with the expression change of the TF (Methods and Fig. 1.2). 
For example, genes that were positively correlated with a TF that was 
specifically up-regulated in humans were only retained if they were also 
specifically up-regulated in humans. Vice versa, genes that were 
negatively correlated with a TF that was specifically up-regulated in 
humans were only retained if they were specifically down-regulated in 
humans. We proceeded analogously for down-regulated TFs and for the 
other species. From the genes assembled this way for each TF we 
constructed another TF wTO network for each species. In contrast to the 
networks above, these TF wTO networks (EC-sub-networks) contain only 
the TFs specifically changed in expression in that species and the 
information of their correlated genes that have also changed specifically in 
that species.  
We validated that the EC-sub-network of each species is different from 
random networks with permutation tests and determined a |wTO| cutoff of 
> 0.3 as the most suitable wTO cutoff for our further analysis (|wTO| > 0.3; 
permutation test, p-value < 0.001) (Methods). To further confirm our 
inferred network links, we tested for enrichment of TF binding sites in the 
promoters of TF correlated and expression changed genes (Methods). For 
the genes contributing to the human EC-sub-network we found for 
instance an enrichment for binding sites of several human specifically 
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changed TFs (e.g CLOCK, EGR1, HNF4A, LMO2, PRDM14, and 
SMAD2), lending support for the biological relevance of the inferred EC-
sub-networks.  
Using the rhesus macaque as outgroup, we focused on the human and 
chimpanzee TF network differences in adult and development PFC. 
Interestingly, the topology of the networks of the two species (Fig 1.6) is 
considerably different. Remarkably, the human life-span EC-sub-network 
has significantly higher connectivity (c = 7.8) than the chimpanzee life-
span EC-sub-network (c = 3.4, Wilcoxon test, p = 4.85x10-05). Such higher 
connectivity has been also confirmed in the EC-sub networks derived from 
the adult PFC data (human c = 15.7, chimpanzee c = 6.8, Wilcoxon test, p 
= 3.3x10-09). Strikingly, “Brain TFs” had more links than other TFs in the 
adult human EC-sub-networks (adult, Wilcoxon test, p = 0.035; 
development, Wilcoxon test, p = 0.12) and also more links in the human 
adult EC-sub-network compared with chimpanzee adult EC-sub-network 
(adult, Wilcoxon test, p = 1.04x10-05; life-span, Wilcoxon test, p = 0.08), 
suggesting a more central role for those “Brain-TFs” in the human PFC 
(Appendix: Fig. S1.4).  
To identify the most important TFs in the EC-sub-networks, we 
investigated, which TFs have the highest numbers of links, i.e. are hubs in 
the EC-sub-networks. In line with the higher connectivity, “Brain TFs” are 
significantly enriched among the hubs (adult, Fisher’s exact test, p-value = 
0.03; development, Fisher’s exact test, p-value = 0.32) only in human adult 
EC-sub-network. Examples of hubs in the human EC-sub-networks 
(defined as TFs with more than 18 links) are the aforementioned CC2D1A, 
and ZNF536, zinc finger protein implicated in maintenance of neural 
progenitor cells and neuronal differentiation (Qin et al. 2009).  
Besides hubs, nodes with high Betweenness Centrality are also important 
for networks. These nodes are characterized by the highest number of 
shortest paths passing through them, making them in modular networks 
the nodes that are connecting the modules. We found several TFs (e.g. 
ZIC1, ZNF24, and ZNF331) that are central node in the network with their 
centrality function conserved between adult and life-span PFC. This data 
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emphasize the central role of some TFs in the molecular pathways of 
human PFC.  
Moreover, life-span and adult networks of both human and chimpanzee 
highlighted variation in TF connectivity (Appendix: Fig. S1.5 and Fig. 
S1.6). While TFs such as CC2D1A, RBPJ, and ZNF536 maintained high 
connectivity in both human EC-sub-networks, in TFs as APPB2, KCNIP1, 
and ZIC1 the connectivity between adult or life-span PFC drastically 
changed. This data suggests that several TFs might have a selective hub 
role during life-span stages of PFC.  
Interestingly, genes correlated with the TFs in the human EC-sub-network 
are enriched for genes involved in axon guidance, myelination, and cell 
differentiation. Such functions are not overrepresented in the chimpanzee 
EC-sub-networks. This is remarkable, given that very similar GO groups 
have been enriched in the five networks built from all correlated genes, 
indicating that while the overall function of the PFC network seems to be 
conserved since the human-chimpanzee-rhesus macaque ancestor, TF 
genes with human specific expression seem to particularly change the 
expression of genes involved in certain brain functions.  
Because the EC-sub-networks are bi-modular, we also tested for GO 
enrichment among the genes of each module (Methods). While the 
chimpanzee modules did not shown any significant enrichment, the human 
right module was enriched for genes involved in cellular differentiation and 
morphogenesis. Strikingly, we found that the human left module showed a 
significant enrichment within GO groups related to axon guidance, 











Figure 1.6: Lineage EC-sub networks. On the top part, the adult EC-sub-
network and on the bottom, the developmental EC-sub-network. (A) 
Human EC-sub-networks. (B) Chimpanzee EC-sub-networks. In red, we 
showed the up-regulated TFs. In green, we showed the down-regulated 
TFs. Links showed the directionality. 	  
 
Discussion 
Multiple studies have pointed out difference in expression profiling of 
primate brains (Enard et al. 2002a; Cáceres et al. 2003; Somel et al. 2009; 
Babbitt et al. 2010; Liu et al. 2012) but few highlighted differences in co-
expression networks in primate brain regions (Oldham et al. 2006; 
Konopka et al. 2012). While our previous work (Nowick et al. 2009) has 
revealed differences in a TF co-expression network between human and 
chimpanzee brains, it did not allow to pinpoint changes that were specific 
to the human PFC. To provide a better understanding of transcriptional 
evolution in primate PFCs, we identified here TFs with human, 
chimpanzee, and rhesus macaque specific expression in the PFC and 
investigated their potential interactions and target genes using a network 
approach.  
Comparing the networks of these changed TFs between the three 
species, we inferred the ancestral human-chimpanzee and human-
chimpanzee-rhesus macaque networks and identified species-specific 
interactions. We showed that in the brain – but not in other tissues – the 
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human wTO network experienced extraordinary rewiring. Furthermore we 
constructed sub-networks of only the TFs and genes with species-specific 
expression changes (EC-sub-networks) to pinpoint network components 
that might underlie phenotypic differences between species in the PFC. 
With this our work not only highlights the complexity of transcriptional 
networks in human brain regions with a focus on the PFC, but also adds to 
previous findings on human specific morphological changes in the PFC 
(Semendeferi et al. 2011; Rilling 2014), and human specific gene 
expression changes in the PFC (Somel et al. 2009; Babbitt et al. 2010; 
Konopka et al. 2012; Liu et al. 2012), by suggesting candidate TFs and 
interactions that might drive these human specific changes. Our study has 
several limitations.  
For example, our restriction to data from humans, chimpanzees, and 
rhesus macaques, does not allow us to determine the exact time window 
of when particular network rewiring events took place. Moreover, because 
we can only observe links that exist in presently living species, our 
ancestral networks do not contain links that have been lost during 
evolution. It should also be kept in mind that not all gene expression 
changes reflect on the protein level. Nevertheless our work provides 
insights into network rewiring process that took place during human and 
chimpanzee evolution.  
The most intriguing insight from our work is that we demonstrated higher 
connectivity and more rewiring in the TF network of the human PFC 
compared to the chimpanzee PFC TF network.  Importantly, we obtained 
this result with data from two independent genome-wide expression 
studies of primate PFC samples, Increased network connectivity in the 
human compared to chimpanzee and rhesus macaque PFC has also been 
described with another study with a different network approach (Konopka 
et al. 2012).  
In our data, higher connectivity between TFs means that the TFs overlap 
more strongly in their putative target genes and interaction partners. This 
suggests changes in gene regulatory programs with a more complex 
interplay of TFs in the human PFC. Several hubs that experienced strong 
rewiring in the human PFC network are known to be involved in important 
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brain functions, for instance CC2D1A, MEF2D, and PER2. The function of 
other hubs with strongly changed links, such as ZNF19, ZNF286A, and 
ZNF696, has yet to be discovered. Interestingly, among the most highly 
connected TFs in the human EC-sub-network are TFs that have been 
implicated in brain development and cognitive diseases. It is possible that 
these TFs became risk genes for brain disorders, because they moved 
into such central position in the human network. In contrast, we did not 
find enrichment for or higher connectivity of “Brain TFs” in the chimpanzee 
and rhesus macaque EC-sub-networks, suggesting that human specific 
changes in network integration of some “Brain-TFs” might in part be 
associated with the evolution of human-specific cognitive abilities.  
Our GO analysis showed that already the ancestral PFC TF network 
regulates primarily genes involved in brain development and brain 
functions. Some of the rewiring that we observed might compensate for 
other mutations during primate evolution to keep the expression of genes 
in the brain conserved. This implies that in part some molecular pathways 
are regulated differentially across different primate species.  
To identify the network components that are most likely responsible for 
phenotypic differences between the three species, we identified the subset 
of TFs and their correlated genes with species-specific expression.  
Only on the human lineage, these genes were enriched for genes that are 
involved in neuron projection, cell morphogenesis, neuron development, 
neuron differentiation, and axonogenesis. This suggests that the TFs of 
the human EC-sub-network and the genes they regulate as excellent 
candidates for setting the stage for human specific cognitive abilities. For 
example, APBB2, associated with Alzheimer’s disease (Li et al. 2005; 
Golanska et al. 2008), RBPJ, important for neuronal plasticity and 
development (Hanotel et al. 2014; Liu et al. 2014b), and NRIP1, a target of 
FMRP and potentially implicated in intellectual disability (Darnell et al. 
2011), are hubs in the human EC-sub-networks and strongly interlinked. In 
summary, our results suggest that the network of TFs in the PFC has 
been heavily rewired during primate evolution. While we noted 
considerable rewiring also in other brain regions, we did not observe it in 
other tissues We yet have to understand better the complexity of gene 
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regulatory networks and their phenotypic consequences, but the TF 
network changes we identified here might have changed the expression of 
gene that are involved in determining human specific traits, such as bigger 
brain size, particular cognitive abilities, behavior, and brain disorders.   
Methods 
Data sets 
Raw data for microarray and RNA-Seq were downloaded from Gene 
Omibus Database (http://www.ncbi.nlm.nih.gov/geo/). For the differential 
expression profiling, we used data of the PFC of 5 adult of human, 
chimpanzee and rhesus macaque individuals (GSE50782). For the 
correlation analyses, we used a two dataset: the multi tissue RNA seq 
dataset comprising adult individuals of human, chimpanzee and rhesus 
macaque (GSE49379) and an additional microarray dataset of PFC 
samples selecting 12 individuals for each species with different ages 
(GSE22570). For a comparable age collection, we implemented a linear 
model using the specific life traits of each species such as sexual maturity, 
first reproduction, age at gestation, litter per year, weaning, and maximum 
life expectancy. 
 
Expression profiling  
RNA-seq and Microarrays were analyzed using the R programming 
language and Bioconductor packages. RNA-seq were aligned to primate 
genomes (hg19, PanTro3, rheMac3) using seghemel (Hoffmann et al. 
2009). Counts and RPKM were calculated using R programming and 
multiple library (Lawrence et al. 2013a). We retained expressed genes 
with RPKM > 0.5 in at least one species. Counts were further confirmed 
using HTSeq (Anders et al. 2014). Orthologous genes were used and 
human gene names were selected for further analysis. Differential 
expression were calculated using DESeq package (Anders and Huber 
2012). Genes were retained differentially expressed for |log2FC| > 0.3 and 
FDR < 0.05.  For the microarray dataset, we performed a computational 
mask procedure using the maskBAD package 
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(http://bioinf.eva.mpg.de/masking/) (Dannemann et al. 2009). This 
removed probes with binding affinity differences between species. For 
further analysis, we only considered the probe sets with more than four 
probes left after masking.   
We determine gene expression levels (RMA values) and MAS5 detection 
p-value from the remaining probes using the “affy” package (Gautier et al. 
2004). We considered only the probe sets significantly detected in at least 
one individual (p-value < 0.05). Furthermore, for genes represented by 
more than one expressed probe set, we calculated the mean of the 
expression values of all its probesets. The list of all TFs was taken from 
TFcheckpoint (Chawla et al. 2013) in which they selected and manually 
curated genes coding for TFs. 
 
Correlation analysis 
We performed Spearman rank correlations between the expression values 
of each of changed-TFs and expressed genes. To derive the networks 
incorporating all significantly (p-value < 0.05) correlated genes, we 
calculated the wTO values as previously described (Nowick et al. 2009). 
Briefly, we calculated a wTO matrix starting from the adjacency matrix A = 
[𝑎!"], with 𝑎!" = 𝐶𝑜𝑟𝑟(!") ϵ [-1, 1] and 𝑎!"   = 0, where i and j represent the 645 
differentially expressed TFs. Our method incorporates the correlations of 
two TFs associated gene sets denoted as u. Our approach further 
considers the positive and negative correlations as following: 𝑎!" ϵ [-1, 1] 
when 𝑎!" ≥ 0 → 𝑎!"𝑎!" ≥ 0 for all u and 𝑎!" ϵ [-1, 1] when 𝑎!" ≤ 0 → 𝑎!"𝑎!" ≤ 
0 for all u. Inserting the weighted connectivity of a node i as: 
 𝐾!   =    𝑎!"! , then:  
 
𝜔!" =   
𝑎!"𝑎!"   +   𝑎!"   !












Gene ontology enrichment were performer using FUNC (Prufer et al. 
2007) and additional confirmation with GOstat (Beißbarth and Speed 
2004) and GOrilla (Eden et al. 2009). We adapted the Wilcoxon ranked 
enrichment ranking the genes based on the number of TFs the genes are 
correlated with. We report GO groups with enrichment p-values < 0.05 
before and after refinement. For the EC-sub-networks, FUNC was 
adapted (Prufer et al. 2007; Huang et al. 2008), performing a similar 
Wilcoxon test we used previously. We reported GO categories enrichment 
for a p-values < 0.05 before and after refinement. For module enrichment, 
we subset the genes correlated with the TF in the modules and adapted a 
Wilcoxon ranked enrichment.  
TF enrichment 
We performed the TF motif enrichment using the Jaspar and TRANSFAC 
databases (Matys et al. 2003; Mathelier et al. 2013). We compared the 5 
KB upstream promoter regions to three different background data: 5 and 2 
KB promoter regions of all human genes and Human CpG islands. To 
perform the motif enrichment, we used MEME suite (Bailey et al. 2009). 
Motifs enrichment were additionally confirmed using publically available 
ChIP data from ENCODE and other sources using ChEA suite (Lachmann 
et al. 2010).  
 
Network robustness tests 
To test the robustness of the networks, we performed two different 
methods: Firstly, we performed a permutation test shuffling 1000 times the 
expression values of all expressed genes. We then calculated the wTO 
values with these randomized expression values. The randomized 
networks showed fewer links and high structural differences compared 
with the original networks of all species for all tested cutoffs |wTO|= [0.2 .. 
0.6],  resulting in a p-value of 0.001. None of the randomized networks 
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displayed edges with |wTO| > 0.3. Subsequently, we applied |wTO| > 0.3 
for the PFC developmental data. Due to the high number of edges on the 
adult data, we adapted a |wTO| > 0.5 cutoff for a better and consistent 
data visualization and analysis.    
For the EC-sub-network, we performed 1000 permutation tests. The 
structures of the randomized networks were considerably different from 
the original network. Since none of the 1000 shuffled networks presented 
wTO values higher than 0.3 (p-value = 0.001), we chose |wTO| > 0.3 as 
cutoff for the EC-sub-networks. 
An additional test for the network evolution of the PFC developmental 
dataset has been implemented. To test if this high number of species-
specific links could be an artifact, we recalculated the networks using the 
“leave-one-out” method. This resulted in 12 networks per species 
constructed from 11 individuals each. All these networks clustered 
according to species, demonstrating that the strong divergence in network 
links between species is robust. 
 
Other statistics 
To test the brain-TF enrichment, P-values were calculated with Fisher’s 
exact test function in R (alternative = “g”, confidence level = 0.99, 
simulated p-value with 1000 replicates). Wilcoxon ranked test was 
implemented to evaluate the difference of the connectivity between 
species (alternative = “g”, confidence level = 0.99, paired=FALSE).  
To test the overlap between independent data, P-values were calculated 
with hypergeometric test using a custom made R script. We retained an 
independent background for population size (for human, BrainSpan 
expressed gene = 15585 genes). P-values were subsequently adjusted for 
multiple comparisons using Benjamini-Hochberg FDR procedure. Two-
way permutation test of 10000 was adapted to validate the overlaps. First 
we randomize the external gene sets (e.g human DEGs) randomly 
selecting the same number of genes from an independent brain expressed 
genes list (Brainspan gene set) and subsequently calculating the overlap 
P-values with the TF gene set. The second approach randomized the 
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internal gene sets (e.g. TF gene set) randomly selecting the same number 
of TF detected from RNA-seq and subsequently calculating the overlap P-
values. Moreover, we adapted a permutation test to evaluate the detected 
DEG, randomizing 1000 times the RNA-seq data and recalculating the 
DEG detecting that none of the permuted data showed the same DEG 
(data not shown). Analysis for RNA-seq, microarray, and correlation 
filtering were performed using custom made R and SQL scripts 
implementing functions and adapting statistical designs comprised in the 









CHAPTER 2  
A transcription factor consensus network of the 
human frontal lobe: insights into the molecular 
mechanisms of human cognitive abilities 
Project summary 
Cognitive abilities, such as memory, learning, language, problem solving, 
and planning, involve the frontal lobe and other brain areas. Not much is 
known yet about the molecular basis of cognitive abilities, but it seems 
clear that cognitive abilities are determined by the interplay of many 
genes. One approach to analyze the genetic networks involved in 
cognitive functions is to study the co-expression networks of genes with 
known importance for proper cognitive functions, such as genes that have 
been associated with cognitive disorders like intellectual disability (ID) or 
autism spectrum disorders (ASD). Because many of these genes are 
transcription factors (TFs) we aimed to provide insights into the gene 
regulatory networks active in the human frontal lobe. To this end, we 
derived co-expression networks for all TFs including their potential target 
genes and interaction partners from 10 independent genome wide 
expression studies from different experimental platforms from human 
frontal lobe samples. We developed a new statistical method for 
integrating multiple independently derived networks into a high confident 
consensus network. This consensus network revealed robust TFs 
interactions that are conserved across the frontal lobes of different human 
individuals. Within this network, we detected a strong central module that 
is enriched for TFs known to be involved in brain development and/or 
cognitive disorders. Interestingly, also many hub genes in this module are 




light on which TF genes play a central role in a regulatory network of the 
human frontal lobe. 
Introduction 
Broadly defined, cognition refers to the biological mechanisms through 
which animals perceive, learn and memorize information from the 
environment and decide to act upon them (Shettleworth 2009). In humans, 
cognitive processes such as language, social behavior, and decision 
making have been attributed to the frontal lobe (Duncan et al. 1996; 
Chayer and Freedman 2001). Chimpanzees and bonobos share many 
intellectual and social capabilities with humans, suggesting a common 
evolutionary trajectory in the great-ape lineage. Nevertheless, humans are 
distinct from other apes by having for instance more complex social and 
communicative skills. These abilities seem to be linked to a larger and 
morphologically more complex frontal lobe in humans (Squire and Zola 
1996; Boyd et al. 2011; Neubert et al. 2014). Indeed, the human frontal 
lobe has a wider spacing between its cortical mini-columns compared to 
the other great apes (Buxhoeveden et al. 2006; Semendeferi et al. 2011). 
It also shows higher connectivity and a pronounced increase of white 
matter during development (Schoenemann et al. 2005; Rilling et al. 2008). 
In addition, there is a positive correlation between the expansion of the 
neocortex and the measures of social complexity in primates (Dunbar and 
Shultz 2007).  
These findings suggest that morphological and histological changes in the 
human frontal lobe have been involved in the evolution of human specific 
cognitive traits. However, the actual molecular mechanisms that underlie 
these morphological changes are still not well understood. Candidate 
genes that are involved in the molecular mechanisms of cognition can be 
identified through biomedical studies on cognitive disorders. For example, 
causative mutations point to the genes that should in their wild-type 
variants be important for providing for healthy cognitive abilities. Research 
on cognitive disorders such as Alzheimer’s disease (AD) (Bullido et al. 




disorder (ASD) (Bailey et al. 1996; Voineagu et al. 2011; Berg and 
Geschwind 2012; Ecker et al. 2012), schizophrenia (SZ) (Andreasen 
1995), circadian rhythm and bipolar disorder (BD) (Scrandis 2014), 
Parkinson’s disease (PD) (Polymeropoulos 2000), and several syndromes 
or disorders associated with ID or cognitive impairment (SY) (Greydanus 
and Pratt 2005) has thus already identified several candidate genes 
involved in cognition. Importantly, these studies also revealed that most 
cognitive disorders are complex and phenotypically and genetically 
heterogeneous (Sebat et al. 2007; Tsankova et al. 2007; Voineagu et al. 
2011; Weyn-Vanhentenryck et al. 2014), thus creating challenges for 
studying these disorders. Transcriptome and network analyses bear great 
potential for overcoming some of these challenges and uncovering the 
genetic interactions and molecular mechanisms causing such complex 
disorders. For example, recent studies have used network approaches to 
identify coexpressed ASD and ID modules implicated in synaptic 
development, chromatin remodeling and early transcriptional regulation 
(Parikshak et al. 2013; Willsey et al. 2013; De Rubeis et al. 2014).  
Several reasons prompted us to especially focus on the investigation of 
the role of TFs in co-expression networks of the frontal lobe. First, 
because TFs regulate the expression of many genes, they are expected to 
be among the most important players in these networks and might provide 
important insides about the molecular mechanisms taking place in this 
tissue. Second, our previous work (Nowick et al. 2009) showed that TFs of 
the family of KRAB-ZNFs, among them many primate specific TFs, are 
enriched among the genes showing differential expression patterns 
between the human and chimpanzee frontal lobe. In addition, primate 
specific KRAB-ZNFs are also enriched among the genes expressed 
during frontal lobe development (Nowick et al. 2010), which leads to the 
hypothesis that at least some TFs, might contribute to human specific 
cognitive abilities. Third, we show here that TFs are enriched among the 
candidate genes for ID and ASD, thus suggesting an important role of TFs 
in the gene regulatory processes and circuitry of such cognitive disorders. 




information about the molecular mechanisms that set the stage for 
cognition. 
To identify and analyze TFs with potential implications in cognition in more 
detail, we performed a comprehensive literature survey and compiled a list 
of 515 TFs that are known to be important during human brain 
development or that have been associated with cognitive disorders. We 
will refer to this set of 515 TFs as “Brain-TFs”.  We then derived co-
expression networks, which integrate all TFs and their correlated genes 
which are expressed in human frontal lobes. Because co-expression 
networks can have many false positive inferences, we calculated weighted 
topological overlap (wTO) networks, which significantly reduce the effect 
of false positives (Nowick et al. 2009). In addition, to reduce the effect of 
individual differences and technical artifacts, we analyzed 10 different 
transcriptome datasets from individual human frontal lobe samples, which 
have been produced with different platforms (microarrays and RNA-Seq). 
We then developed a method for integrating the wTO networks of these 
10 different datasets to obtain a consensus network with high confidence 
level. Using this consensus network we particularly investigated the 





Transcription factors in cognition, brain development and 
disorders  
To investigate TFs that are expressed in the frontal lobe more 
comprehensively, we used our in-house list of all 3315 human TFs 
(Perdomo-Sabogal et al., manuscript in preparation). Note that we are 
using the term TF here for transcriptional regulators, which include DNA 
binding proteins, cofactors, and chromatin modifiers among others. Within 
this list of TFs we identified 515 TFs that are involved in cognitive 
functions, brain development, and disorders by using different sources: 
Simons Foundations Autism Research Initiative (Banerjee-Basu and 
Packer 2010), AutDB database (Basu et al. 2009), PubMed, Online 
Mendelian Inheritance in Man (Hamosh et al. 2005), AlzGene (Bertram 
2009) PDgene (Lill et al. 2012), SZgene (Allen et al. 2008), and from 
multiple publications on genes associated with intellectual disability (Inlow 
and Restifo 2004; Ropers 2008; van Bokhoven 2011; Lubs et al. 2012) 
(Appendix: Table S1.1).  
A prevalence of genes coding for TFs among genes associated with some 
cognitive disorders has been observed before (Voineagu et al. 2011; 
Parikshak et al. 2013; Willsey et al. 2013). We here tested if this 
observation represents a significant overrepresentation of TF genes 
among genes implicated in cognitive disorders. Among the 401 genes 
implicated in Intellectual Disability (ID), we identified 106 genes coding for 
TFs, which represents a highly significant enrichment of TFs among all ID 
genes (hypergeometric test, p = 2.03x 10-07) (Fig. 2.1). The AutDB and 
SFARI databases (Basu et al. 2009; Banerjee-Basu and Packer 2010) 
currently include 667 genes implicated in autism. We identified 141 TFs 
among these 667 genes, which demonstrates that there is also a highly 
significant overrepresentation of TFs among genes associated with autism 
(hypergeometric test, p = 0.0004) (Fig. 2.1). We further investigated 




Retardation Protein (FMRP). This protein was previously shown to play an 
important role in ASD-pathways by exerting translational regulation during 
human brain development (Darnell et al. 2011). Among the set of 842 
FMRP targets predicted by HITs-CLIP, we identified 179 TFs revealing a 
significant overrepresentation of TF genes (hypergeometric test, p = 
0.0001) (Fig. 2.1). Taken together, these findings show that TFs are 
enriched among candidate genes for cognitive disorders and suggests 
that many TFs play a critical role in the molecular processes involved in 
the organization and functioning of neural circuits that support healthy 
cognitive abilities.  
 
 
Fig. 2.1: Brain-TFs association. Overlap between TFs implicated in 
autism (ASD) or intellectual disability (ID), TFs that are FMRP targets 
(FMRP), TFs involved in brain development and functions (BrD), and 
TFs implicated in syndromes or disorders (DIS). Empty space 
represents no overlap between sets. The overlap shows the 





Ten different genome-wide TFs co-expression networks  
To investigate the roles of all TFs in the frontal lobe, we analyzed ten 
genome-wide expression datasets comprised of frontal lobe samples from 
individuals of different ages and obtained with different techniques. We 
considered these independent dataset as replicates, thus helping us to 
alleviate the dependence of our results from a particular set of individuals, 
developmental time points, different RNA library preparations, and gene 
expression measurement platforms.  
From each dataset, we constructed a weighted topological overlap (wTO) 
network taking into account all expressed TFs and their coexpressed 
genes (Nowick et al. 2009). For constructing this wTO network, we first 
identified all genes that are significantly correlated in expression (i.e. 
coexpressed) with a particular TF. These genes include putative target 
genes and interaction partners of that TF. The wTO of a pair of TFs then 
represents the commonality of these two TFs in their sets of coexpressed 
genes. Because TFs can function as activators or repressors of gene 
expression, we take into account the sign of the correlation when 
calculating the wTO. Pairs of TFs with |wTO| values above a certain cutoff 
are connected by a link in the wTO network visualization (Methods).  
To evaluate the reliability of the 10 networks, we performed permutation 
tests by randomizing the expression values for each individual 100 times 
and calculating the wTO values for these randomized datasets. For any 
tested |wTO| cutoff, the networks obtained from the real datasets had 
more links than the networks from the permuted datasets, indicating that 
all empirically derived networks are different from random expectation. 
Nevertheless, we also noted differences between the 10 networks, for 
instance in the distribution of the wTO values and when comparing the 
wTO values for particular links between the datasets (Fig. 2.2 A,B). The 
differences between the datasets can probably be explained by biological 
variation between individuals, but also by technical variations such as in 
RNA extraction methods, RIN values, and RNA library preparation 




wTO values that are distant from the other wTO values as outliers. We 
observed that the dataset BipRVal differs the most from the other datasets 
by having the highest number of wTO outliers, followed by datasets DisVal 
and FrontalVal (Fig. 2.2 C and Fig. S2.1). Based on these observations 
we decided to choose Wilcoxon rank sum tests for our subsequent 
analyses, because as a nonparametric test it is robust against outliers.  
 
 
Fig. S2.1. Multidimensional scaling plot based on Pearson correlations. 
The circles represent the datasets used in this study.  The BipRVal 
dataset is the most different dataset compared to the other datasets. The 
three BrainSpan datasets (DfcVal, OfcVal, VfcVal) cluster together. The 
microarray datasets (GexVal, NeoVal, DisVal, BipVal) showed a 
consistent clustering with one additional RNA-seq dataset (KhatVal). 
FrontalVal is not clustering with any of the other microarray or RNA-Seq 
datasets. This clustering suggests that the wTO networks do not simply 












Fig. 2.2: Overview differences and similarities between datasets. (A) 
Representation of the distribution of the wTO values of the 10 datasets. 
On the right side, a wTO density plot. On the top, a clustering map of the 
datasets showing FrontalVal and BipRVal as outliers compared with the 
remaining datasets. (B) Overall stripe chart of the wTO values across the 
10 datasets. Red represents positive wTO values whereas blue 
represents negative wTO values. As also seen in Fig. 2A, FrontalVal and 
BipRVal wTO values differ most from the other datasets. (C) Barplot 
representing the numbers of detected wTO outlier values (wTO-ov) per 
dataset. BipRVal contained the highest number of outliers underlining it as 




The consensus network 
In total we found that 19% (287930) of all links between TFs are present in 
all 10 wTO networks. These links thus seem to represent conserved 
functional associations between TFs in the human frontal lobe. To focus 
on these conserved network links, we developed a method to combine all 
the independently derived networks into one consensus network for the 
human frontal lobe with higher confidence level (Methods). A link in the 
consensus network was considered for further analysis and network 
visualization if the distribution of its wTO values across the 10 dataset was 
significantly higher than the chosen cutoff (Wilcoxon rank sum test, 
p<0.05; Fig. 2.3).  
 
Fig. 2.3: Consensus method. Schematic representation of the method we 
implemented for combining multiple networks into a consensus network. 
The examples shown in the first part highlight hypothetical interactions 
present in three independent datasets. The numbers on the links 
represent the wTO values calculated using our method. We performed a 
Wilcoxon rank sum test to statistically determine which links had wTO 
values that were significantly higher than a chosen cutoff (|wTO| > 0.3) 
across all datasets. The blue network represents the consensus network 
containing only these significant links. The numbers shown at the links of 
the consensus network are the median wTO values calculated from the 
respective links in the 10 datasets. The links that not full-filled our 
statistical criteria due to high variation between dataset and cutoff 





With the cutoff of |wTO| > 0.3, the resulting consensus network consists of 
2516 links (Fig. 2.4 A). To determine the weight of the links in the 
consensus network, we calculated the mean of all wTO values for the 




Fig. 2.4: High confident consensus network and proteomics networks. (A) 
Representation of the frontal lobe consensus network. Shown are the 
most highly connected hubs (degree > 25). Red nodes highlight Brain-
TFs, while blue nodes represent all other TFs. The size of a node is 
proportional to its number of links: bigger nodes represent hubs in the 
network. Links with positive wTO values are in blue and links negative 
wTO values are shown in red. (B) Brain-TFs and FMRP targets module. 
Red nodes highlight the Brain-TFs, while the green nodes highlight TFs 
that are FMRP targets. The size of the nodes is proportional to their 




The Brain-TFs and their role in the consensus network  
Once generated this high confident consensus network, we analyzed how 
the known Brain-TFs are integrated into this network. Of the total of 515 
Brain-TFs, 127 are present in the consensus network. Interestingly, this 
represents a significant enrichment of Brain-TFs among the 498 TFs of 
the consensus network (Fisher exact test, p = 2.32 x 10-09, OR = 2.1).  
Remarkably, the group of Brain-TFs has a higher connectivity (number of 
links) compared to other TFs in the consensus network (Wilcoxon rank 
sum test, p = 0.023). This finding suggests that known Brain-TFs have 
stronger functional relationships amongst each other than other TFs in the 
frontal lobe.  
To investigate whether the TFs are also highly expressed at protein level 
in a fetal or adult brain, we superimposed our consensus network with a 
proteome map of the human brain at different stages, which was derived 
using mass-spectrometry proteomics (Kim et al. 2014). This strategy 
allowed us to understand the potential roles of the TFs in the period of 
brain development and circuitry formation compared with an adult brain. 
Interestingly, overall the TFs of our consensus network have higher 
expression and significantly more links in the fetal module compared to 
the adult module (Wilcoxon rank sum test, p = 0.006). The known Brain-
TFs are specifically enriched in the fetal module (Fisher exact test, p = 
0.03, OR = 1.5) with generally higher number of links in comparison to 





Figure S2.2: Proteome TF modules with red nodes representing the 
Brain-TFs whereas in blue the Normal-TFs. Links with positive wTO 
values are in blue and links negative wTO values are shown in red. (A) 
Fetal module. (B) Adult module. Brain-TFs are significantly enriched in the 
fetal module showing higher connectivity compared with the other TFs.  
 
Examples of Brain-TFs that are hubs in our consensus network and in the 
fetal module include ADNP, a TF with neuroprotective function and target 
of FMRP (Darnell et al. 2011; Oz et al. 2012), CDK8,  which is genetically 




establishing neuronal polarity (Schwamborn et al. 2007), TCF4, 
associated with BD and SY (Zweier et al. 2007; Rosenfeld et al. 2009), 
and ZNF711, which is associated with X-linked ID (Tarpey et al. 2009).  
We next investigated the interactions between known Brain-TFs and 
FMRP targets to find new candidate TFs with potential implication on brain 
functions (Fig. 2.4 B). We found several FMRP targets that are strongly 
connected with known Brain-TFs, such as ZNF365, a KRAB-ZNF that is 
highly expressed in brain (Nagase et al. 1998), MED13, a subunit of the 
mediator complex (Sato et al. 2004), MAZ, a myc-mediated zing finger 
protein potentially implicated in neurodegeneration (Jordan-Sciutto et al. 
2000), and TLE3, a member of the Notch signaling pathway (Fig. 2.4 B 
and Fig. S2.3). Therefore, TFs like ZNF365, MED13, MAZ, and TLE3 
might be crucially involved in controlling gene expression patterns with 
importance for brain development and healthy cognitive abilities.  
To confirm the transcriptional pathways suggested by our consensus 
network, we examined whether there is enrichment of the TF binding sites 
in the regulatory sequences of the 5421 genes that are correlated with at 
least one of the 498 TFs of the consensus network. To this end, we first 
performed a ChIP enrichment analysis (ChEA) using the updated 
ENCODE database and a manually curated list of target genes uncovered 
by ChIP-Seq, Chip-chip, ChIP-PET, and  DamID from multiple studies 
(Lachmann et al. 2010). We found that the TFBS of 55 TFs in the 
consensus network are significantly enriched among the regulatory 
sequences of the 5421 genes (p < 0.05 after Benjamini-Hochberg 
correction). Among those 55 TFs, we found for instance a histone 
deacetylase (HDAC2) involved in synaptic plasticity and neural circuits 
(Guan et al. 2009), an activating transcription factor (ATF2) linked to 
neuronal apoptosis and cell migration (Yuan et al. 2009), and a 
chromodomain transcription factor (CHD2) implicated in ASD and epilepsy 
(Rauch et al. 2012). Secondly, using the Jaspar and Jolma databases, we 
found an enrichment of binding sites for 34 additional TFs of the 
consensus network within the 2kb region upstream of the transcription 




Hochberg correction) (Jolma et al. 2013; Mathelier et al. 2013). Here, we 
found enrichment for binding sites of ARNTL, a transcription factor 
important for circadian rhythm associated with BD (Nievergelt et al. 2006), 
MEF2D, a myocyte transcription factor involved in neuronal differentiation 
and PD (Yang et al. 2009), and MEF2C, another myocyte transcription 
factor involved in ASD, ID and epilepsy (Novara et al. 2010) among 
others.  
Coexpressed genes can also indicate protein interaction partners. Thus, 
we next examined protein – protein interactions (PPI) among the 498 TFs 
and the 5421 correlated genes utilizing the annotations from BioGRID and 
InWeb (Stark et al. 2006; Chatr-Aryamontri et al. 2013). We found that 
correlated TF-gene pairs were significantly enriched within the PPI 
interactions (Fisher exact test, p = 2.2 x 10-06, OR > 3), thus providing an 
additional confirmation of the potential functional interactions between TFs 
and their correlated genes.  
To infer more about the functions of the potential target genes of the TFs 
in the consensus network, we performed a Gene Ontology (GO) 
enrichment analysis among the 5421 genes correlated with at least one 
TF in all 10 datasets (Methods). For this analysis, we ranked all genes 
according to the number of TFs they are correlated with in each dataset 
and then summarized the ranks across all datasets. We then tested for 
GO enrichment among the genes with high ranked sums. We found 
significant enrichment for genes involved in metabolism, signaling, 
transport, translation, and RNA splicing (Fig. 2.5 A). Interestingly, these 
GO categories seem to be important for several brain functions: for 
instance translational mechanisms have been shown to play a role in 
memory formation and synaptic plasticity (Richter and Klann 2009) and 
RNA splicing mechanisms have been implicated in neuronal development 
and ASD (Li et al. 2007; Weyn-Vanhentenryck et al. 2014).  
We also specifically tested for GO enrichment of the genes correlated with 
three Brain-TFs that are the strongest hubs in the consensus network: 
ADNP, ZNF711 and ZNF74. We performed a hypergeometric test for each 




summarized the 10 lists of significant GO categories into one single list 
per TF. Overall, we found similar GO groups enriched for these hubs like 
we did for the consensus network as a whole. However, there were also 
hub-specifically enriched GO categories such as brain development, 
methylation, and regulation of synaptic transmission, which suggests a 
specific role of these three TFs in the regulation of genes important for 
these particular brain functions (Fig. 2.5 B, C, D).  Our results together 
indicate that the hub TFs of the frontal lobe consensus network are likely 
to strongly interact to predominantly regulate metabolism, signaling, 
splicing, and synaptic transmission in the frontal lobe.  
 
Discussion 
Understanding the characteristic complexity of cognitive disorders, such 
as ASD and ID, still represents a challenge in neurosciences. In this study, 
we specifically compiled a set of 515 “Brain-TF” genes implicated in brain 
development and cognitive disorders to gain insights into which gene 
regulatory mechanisms these genes may be involved in. We focused on 
co-expression patterns in the frontal lobe, one of the main brain regions 
associated with cognition and behavior. In particular, we developed a 
method for integrating the information from 10 independent datasets 
generated from frontal lobe expression studies, which allowed us to infer 
TF interactions with statistically high confidence. In the TF consensus 
network derived this way, we revealed a significant enrichment of Brain-
TFs, including TFs implicated in ASD, ID, or SY. Many Brain-TFs are 
preferentially correlated with genes involved in functions such as 
axonogenesis, brain development and synaptic transmission. The 
structure and organization of the consensus network we are presenting 
here provides insights into regulatory circuits and pathologies of the frontal 
lobe.  
In order to combine different datasets encompassing various biological 
and technical variations we implemented a conservative strategy for 




relationships between TFs associated with different functional processes 
in human frontal lobes. Despite limitations in the currently available 
functional information about TF genes, we validated some of the inferred 
relationships. For example, we detected enrichment of TFBS for some 
TFs with a known binding motif among the regulatory sequences of their 
correlated genes and enrichment of known TF-TF protein interactions 
among the links of our consensus network.  
Remarkably, we found that Brain-TFs have significantly more links in the 
frontal lobe consensus network than other TFs, demonstrating that they 
are essential regulators of the molecular networks in the human frontal 
lobe. Interestingly we further found that TFs that are involved in cognitive 
disorders are among the most connected TFs in the frontal lobe network. 
For instance,  ZNF711, associated with ID (Tarpey et al. 2009), ADNP, a 
neuroprotective protein involved in ID and ASD (Helsmoortel et al. 2014; 
Iossifov et al. 2014), and ZNF74, a zinc finger protein involved in ID and 
SY (Ravassard et al. 1999) are hubs in this network. The genes correlated 
with those hubs are enriched for GO categories such as axon 
development, brain development and regulation of synaptic transmission, 
thus underlining their likely role in the human frontal cortex development 
and functions. Another hub in our TF consensus network is MEF2C, a TF 
that is important for synaptic plasticity and has been implicated in ASD 
(Ebert and Greenberg 2013). Binding sites for MEF2C are significantly 
overrepresented within the 2kb upstream region of the 5421 genes that 
are common to all 10 individual networks. MEF2C is also strongly 
associated with other Brain-TFs such as ZNF711, SOX11, SOX5, and 
PBX1 defining a strongly interconnected module of TFs involved in 






Figure S2.3: Modules of hub Brain-TFs and their strongly connected 
partners. A) ADNP module, B) MEF2C module, C) ZNF74 module, D) 
ZNF711 module, and E) ZNF365 module. Red nodes highlight Brain-TFs 
whereas green nodes represent FMRP targets. Links with positive wTO 
values are in blue and links negative wTO values are shown in red. Each 
hub Brain-TFs is interestingly associated with other known Brain-TFs 
highlighting potential interactions and common pathways. 
 
 
Several hubs of the frontal lobe consensus network are target genes of 
FMRP, pointing to pathways that might be regulated at the post-
transcriptional level: for instance, CREBBP, a TF associated with ASD and 
ID (Barnby et al. 2005), HDAC4, a histone deacetylase implicated in ID 
and ASD (Pinto et al. 2014), ZNF365, which has also been discovered in a 
module strongly associated with ASD in a brain expression study 
(Voineagu et al. 2011), and KDM5B and KDM4B, both lysine demethylase 




network approach (TADA) (De Rubeis et al. 2014; Iossifov et al. 2014). In 
addition to discovering that Brain-TFs are overrepresented among the 
hubs of our consensus network, we also found an enrichment of Brain-TFs 
in the fetal proteome module, supporting the inference that these TFs 
might regulate important processes during brain development (Fig. S2.2).  
Given that links identified with our method are of high confidence and that 
strong links indicate functional relationships between TFs, we can propose 
novel candidate TFs for being important genes in controlling frontal lobe 
functions. For example, ZNF365, a zinc finger protein, is a novel strong 
candidate because it is strongly linked to many Brain-TFs in our network 
and known to be a target of FMRP.  
It is plausible that co-regulation between such novel candidates and Brain-
TFs might be implicated in multiple functional processes in the human 
brain. Other studies have also suggested some TFs as novel candidates 
for brain functions based on the analysis of co-expression modules 
implicated in ASD (Voineagu et al. 2011; Parikshak et al. 2013). We are 
supporting here several of these suggestions, as some of the same TFs 
were detected as hubs in our consensus network: for instance, MAF, a 
leucine zipper TF involved in cell differentiation (Blank and Andrews 
1997), STAT4, a signal transducer involved in immune system 
(Diefenbach et al. 1999), and CREBL2, a cAMP response element binding 
protein involved in cell cycle and cell differentiation (Thomson et al. 2008). 
Moreover some hub genes of our consensus network have recently been 
implicated as ASD risk factors by de novo loss of function mutations (Liu 
et al. 2014a), for instance ZMYM2, a zing finger associated with 
myeloproliferative disorders (Smedley et al. 1998), and MED13L, a 
subunit of the large mediator complex (Sato et al. 2004). Taken together, 
we speculate that these TFs, which had not yet firmly been associated 
with functions in the human brain, play important roles in the regulation of 
frontal lobe functions and might also be involved in ASD and other 
cognitive disorders.  
A yet unanswered question is how the network that we described for the 




or species. We expect that the relevant data for addressing this question 
will become available soon. We also expect that more TFs will be 
discovered to be involved in brain functions. In future studies similar 
strategies as we presented here can then be implemented to enrich our 
knowledge about the molecular basis and regulatory networks underlying 






























Spearman rank correlations were used to correlate the expression values 
of the TFs with the expression values of all genes, separately in each of 
the 10 datasets.  Note that only expressed genes were considered in each 
dataset and that the number of expressed TFs and genes differs between 
the datasets. We extracted all significant correlations (p < 0.05) for 
calculating the weighted topological overlap values (wTO) between all 
pairs of expressed TFs for each dataset as previously described (Nowick 
et al. 2009). The calculation is based on an adjacency matrix A = [𝑎!"], 
with 𝑎!" = 𝐶𝑜𝑟𝑟(!") ϵ [-1, 1] and 𝑎!!   = 0, where i and j represent the TFs in 
the dataset. Our method incorporates positive and negative correlations of 
two TFs’ correlated gene sets (u) described as follow: 𝑎!" ϵ [-1, 1] when 𝑎!" 
≥ 0 → 𝑎!"𝑎!" ≥ 0 for all u and 𝑎!" ϵ [-1, 1] when 𝑎!" ≤ 0 → 𝑎!!𝑎!" ≤ 0 for all u.  
Inserting the weighted connectivity of a node i as: 
 𝐾!   =    𝑎!"! ,  
and the connectivity between i and j as: 




𝑚𝑖𝑛 𝐾! ,𝐾! + 1− 𝑎!"
 
 
To evaluate the reliability of each wTO network, we performed a 
permutation test by randomizing the expression values of each individual 
100 times and thus calculating 100 permuted wTO networks for each 
dataset. We determined the number of links in the empirically derived 
(“real”) network for multiple wTO cutoffs [0.1:0.6] and compared it to the 
number of links with the same wTO cutoff in the 100 permuted networks. 
This method allowed us to determine a p-value for how different the 
empirical networks are from random expectation and to calculate a false 
positive rate for the links in each network. All empirically derived networks 




networks, demonstrating that the empirically derived networks are different 
from random expectation (Table S2).   
 
Consensus calculation 
To calculate the consensus network, we utilized the wTO values of all TF - 
TF pairs that were expressed in all datasets, regardless of their wTO 
value. However, we first evaluated whether some values needed to be 
excluded from the consensus calculation. To this end, we first perform an 
outlier analysis by analyzing the distribution of the wTO values of all TF-
TF pairs across all datasets using the boxplot.stats function in R 
(Williamson et al. 1989) to identify values that are not integrated in the 
general distribution (i.e. outliers). It is clear that the distribution of wTO 
values of the datasets BipRVal, DisVal and FrontalVal are different from 
the wTO values distributions of the other datasets. Based on these 
observations we chose the Wilcoxon rank sum test for our subsequent 
analysis, since it is a non-parametric test and hence robust against 
outliers. Therefore all the datasets and all the wTO values were 
considered for building the consensus network.  To apply a meaningful 
cutoff to the consensus wTO values of each TF-TF pair, we performed 
another Wilcoxon rank sum test with alternative hypothesis greater than 
|wTO| > 0.3 cutoff. We opted for |wTO|>0.3 as cutoff, because this was the 
mean of the cutoffs at which the 10 networks differed from random 
expectation with p<0.01. If the Wilcoxon rank sum test was significant 
(p<0.05), we considered the wTO values of that TF-TF pair as significantly 
higher than the cutoff. By applying this test we avoided potential false 
positive links due to high variation of wTO values across the datasets. For 
all significant TF-TF pairs, we then calculated a consensus wTO value as 
the median of all individual wTO values for each significant link. 
 
GO enrichment  
For the GO enrichment analysis in the consensus network, we first ranked 
the genes according to the number of times they were correlated with at 




to understand the relative importance of a gene in each dataset according 
to the rank position. We next summarized the ranks across the 10 
datasets, thus obtaining a general rank (rank-sum). The GO enrichment 
test was performed using FUNC (Prufer et al. 2007). We used a Wilcoxon 
rank-based test for GO enrichment among the genes with highest rank-
sums. For the GO analyses we only analyzed GO groups with at least 20 
genes per group. We report GO groups with enrichment p-values < 0.01 
before and after refinement.  
For the analysis of GO enrichment among genes correlated with the 
selected Brain-TF hubs we collected for each hub its correlated genes in 
all the 10 dataset. The remaining set of expressed genes was used as 
background set. We used the hypergeometric test implemented in FUNC 
for the GO enrichment analysis considering only GO groups with at least 
20 genes per group. We report GO groups with enrichment p-values < 
0.01 before and after refinement. Finally, we summarized the 10 lists of 
significant GO categories into one single list, thus removing duplicated GO 
categories. We also parsed the analyzed GO categories into a list of 
developmental categories using CateGOrizer (Zhi-Liang et al. 2008). 
 
Data sets  
The raw and processed data from microarrays and RNA-Seq were 
downloaded from ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) and 
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/). 
Microarrays were analyzed using the R programming language and 
Bioconductor packages (Ihaka and Gentleman 1996). For the microarrays, 
we determined gene expression levels (RMA values) and MAS5 detection 
p-value from the probes using the “affy” and “oligo” package, respectively 
of the platform used (Gautier et al. 2004; Carvalho and Irizarry 2010). We 
considered only the probesets significantly detected in at least one 
individual (p-value < 0.05). Furthermore, for genes represented by more 
than one expressed probeset, we calculated the mean of the expression 
values of all its probesets. For the RNA-Seq data, we used published 




analyzed the raw data by mapping of the reads using segemehl 
(Hoffmann et al. 2009) and calculating RPKM values using R 
programming language and R libraries such as GenomicRanges, 
GenomicFeatures, and Rsamtools (Lawrence et al. 2013b). All the raw 
data were mapped to the hg19 genome. All expression values were then 
filtered for RPKM values > 0.5 for 90% of the samples. All samples were 
used from the following datasets: FrontalVal [GSE25219] (Kang et al. 
2011), NeoVal [GSE11512] (Somel et al. 2009), KhatVal [SRA028456] 
(Somel et al. 2011), and GexVal [GSE22521] (Liu et al. 2012). Only the 
data from the control individuals were selected from the DisVal 
[GSE53987], BipRval [GSE53239] (Akula et al. 2014), and BipVal 
[GSE5388] (Ryan et al. 2006) datasets. From the BrainSpan dataset we 
selected the samples from the frontal lobe regions and subset them such 
that individuals with same ages (13 total individuals per dataset) were 
used. 
  
Network visualization  
For network visualization, we used Cytoscape 3.0. Node attributes were 
used according to our manually curated Brain-TFs list, the Human 
Proteome map (Kim et al. 2014), and the FMRP targets from Darnell et al. 
(Darnell et al. 2011).  
 
TFBS enrichment  
For the TFBS enrichment, we focused on the 5421 genes that are 
expressed in all datasets and correlated with at least one TF in each of the 
10 different datasets. To test whether correlated genes might be target 
genes of the respective TF, we performed a ChIP Enrichment Analysis 
(ChEA) using the ENCODE database and data from Chip-Seq, Chip-Chip, 
Chip-PET and DamID experiments (Lachmann et al. 2010). We also 
performed a TFBS enrichment analysis using the Jolma and JASPAR 
databases (Jolma et al. 2013; Mathelier et al. 2013). We tested for 
enrichment of TFBSs included in those databases within the 2 kb 
upstream region of the 5421 genes using the MEME algorithm (Bailey and 




remaining protein coding genes, CpG islands, and the sequence of a 
random chromosome (chromosome 20). 
  
Protein-Protein-Interactions enrichment  
Protein-Protein-Interactions (PPIs) were compiled from BioGRID and 
InWeb using the method described in Perikshak et al. (2013). We used the 
set of 5421 genes commonly expressed in all 10 datasets. Then we 
determined the TF-gene pairs that were called to interact as proteins 
according to BioGRID and InWeb (Rossin et al. 2011; Chatr-Aryamontri et 
al. 2013). TF-gene pairs that were present in each of the 10 datasets and 
were indicated to interact as proteins were then combined to a consensus 
PPI network. Fisher’s exact test was used for testing the enrichment of 


































CHAPTER 3  
ZEB2 functional characterization: insight into 
the evolution of the great-apes 
Introduction 
There is a strong association between TF and the genetic sequence it 
binds and this relationship is essential to understand the difference and 
evolution between species (Wray 2007; Wittkopp and Kalay 2012). Chip-
Seq studies have uncovered the evolutionary dynamics of TFs in multiple 
species with distant relationship (Schmidt et al. 2010; Schwalie et al. 
2013; Ballester et al. 2014) indicating a rapid species-specific gain and 
loss of TF binding sites. Furthermore, functional enhancer has recently 
emerged as undergoing a distinct evolutionary trajectories compared with 
promoter regions, especially in tissues such as heart, liver, and brain 
(Visel et al. 2013; Nord et al. 2015; Villar et al. 2015) emphasizing again 
the potential changes in TF-DNA interactions between closely and 
distantly related species. However the evolution of TF-DNA interactions 
remains largely uncovered for most of the mammalian TFs.  
Furthermore, comparison between human and non-human primates has 
been focused mainly on histone modifications, methylation, and single TF 
Chip-seq (Cain et al. 2011; Zeng et al. 2012; Schwalie et al. 2013; Wang 
et al. 2015), leaving the majority of TFs largely unexplored in human 
evolution.  
To understand the evolutionary dynamics of gene regulatory mechanisms 
in great apes, we functionally characterized a TF, ZEB2, in two cell-types 
of human, chimpanzee and orangutan. 
ZEB2 is a highly conserved protein characterized by two cluster of zinc 




We previously showed that ZEB2 has several human specific interactions 
in human prefrontal cortex compared with chimpanzee, suggesting its role 
in the human brain and potentially in the evolution of human specific 
cognitive abilities  (Nowick et al. 2009). 
ZEB2 has been also implicated in T-cell differentiation (Chang et al. 2014), 
in multiple cancers (Yoshihara et al. 2009; Nam et al. 2012), and neuronal 
crest cell migration during embryonic development (Vandewalle et al. 
2005; Vandewalle et al. 2009). Mutations and protein alteration of ZEB2 
have been linked with Mowat-Wilson syndrome, congenital disease 
associated with cranial malformations, microcephaly, and intellectual 
disability (Cecconi et al. 2008; El-Kasti et al. 2012; Evans et al. 2012; 
Buraniqi and Moodley 2015).  
Taking these data together, we hypothesized that the transcriptional 
mechanisms controlled by ZEB2 of key genes involved in human 
neurodevelopment might have undergone a species-specific evolutionary 
trajectory in great apes with changes in cis-regulatory elements bound by 
ZEB2. 
Due to the technical lack of great apes tissues and cell-types, we tested 
this hypothesis by genome-wide binding of ZEB2 using chromatin immune 
precipitation (ChIP) followed by sequencing in 3 immortalized 
lymphoblastoid cell lines (LCLs) and 1 fibroblast cell line from human, 
chimpanzee, and orangutan individuals, spanning 16 myr of great-apes 
evolution. To confirm the target genes, we further reduced the expression 
of ZEB2 in the same cell-lines via RNAi-mediated knock down and carried 
out RNA-sequencing. 
Using the combination of ChIP-seq and RNA-seq, we demonstrated that 
ZEB2 showed gain and loss of candidate targets in species-specific 










Genomic distribution of ZEB2 binding in three great apes 
We analyzed the evolution of ZEB2 binding sites in LCLs and fibroblasts 
from 3 great-apes, considering an evolutionary time of circa 16 million 
years. We performed chromatin immunoprecipitation (ChIP-seq) in Homo 
sapiens (H), Pan troglodytes (C), and Pongo abelii (O). For each species, 
we included three biological replicates of immortalized lymphoblastoid cell 
lines LCLs and one individual for fibroblasts, using the input DNA as 
control.  
In order to explore the properties of ZEB2 binding sites we categorized the 
ZEB2-bound regions for the three great apes according to cell-type 
variance, the ZEB2 motif and score, and the annotated genes. 
We detected a similar pattern on the distance from the annotated TSSs 
across all the replicates for the individual species (Fig. 3.1 A). Moreover, 
LCLs and fibroblasts have showed cell-specific and shared annotated 
genes (Fig. 3.1 B). Those results indicated that shared events are less 
susceptible to the chromatin states or epigenetic mechanisms the cells are 
affected to. Thus those shared genes and ZEB2-bound regions are likely 







Figure 3.1: (A) Distribution of ZEB2 binding site in promoter, exons, 
introns, and intragenic regions. Most of the human ZEB2 binding are in 
intragenic regions suggesting a potential role of ZEB2 in regulating 
chromatin remodeling. (B) Distribution of ZEB2 target genes in each cell. 
Each replicate showed specific and shared target genes.   
 
Looking at such closely related species inside the primate lineages, we 
detected several shared and species-specific ZEB2-bound regions that 
are conserved in all the cell lines. For instance, AFF4, gene implicated in a 
sever intellectual disability syndrome (Izumi et al. 2015), is a potential 
human specific target gene detected in all the analyzed replicates. 
Instead, GDF9 showed only chimpanzee and orangutan binding indicating 








Figure 3.2: Genomic occupancy of ZEB2-bound regions in the AFF4 and 
GDF9 locus. Highlighted regions that are species-specific or shared 
between great-apes. 
   
 
Between the great-apes analyzed, we found an overall similar pattern of 
ZEB2 binding sites analyzed in the promoter regions (Fig. 3.3 A) and in 
distal promoter region (Fig 3.3 B), emphasizing the conservation of ZEB2 








Figure 3.3: Distribution of ZEB2 binding site in proximal TSS regions. (A) 
ZEB2 has a similar distribution in 5 KB promoter window in human (blue), 
chimpanzee (red), and orangutan (orange). (B) We analyzed 10 KB (blue, 
red, orange windows), 10-100 KB (purple window), > 100 KB (green 
window). ZEB2 has a similar distribution in proximal/distal TSS regions.  
 
 
This similar ZEB2 binding site distribution between great-apes has been 
identified genome-widely, with chromosomes enriched for shared ZEB2-
bound regions and species-specific enriched chromosome regions (Fig 
3.4 A). We also noted an acceleration of ZEB2 occupancy (peaks/million 
years) in human and chimpanzee (2183.5 peaks/myr and 2332.8 
peaks/myr respectively) compared with orangutan (1327.9 peaks/myr), 
suggesting an increased complexity of ZEB2 regulatory mechanisms in 
human and chimpanzee lineage. Comparing the annotated TSSs, we 
found a similar pattern of chromosomal enrichment with high amount of 
ZEB2 occupancy in chromosome 1 and chromosome 6 in human, 
chimpanzee and orangutan.  Interestingly, chromosome 21, chromosome 




binding in human compared with the other great-apes, defining potential 
regions under evolutionary pressure in human lineage (Fig 3.4 B). Such 
chromosomal specificity has been also highlighted by ZEB2-bound 
regions with species-specific and shared ZEB2-bound locations (Fig 3.4 
C). We remarkably detected species-specific targets and shared targets 
and such overlaps are significant (HC, hypergeometric test, p-value = 
1.55x10-179; HO, hypergeometric test, p-value = 5.00x10-111; CO, 
hypergeometric test, p-value = 7.47x10-225) (Fig 3.4 C). Despite the 
difference between great apes, the similar enrichment of ZEB2-bound 
regions per chromosomes and the overlap between ZEB2 targets in 
annotated TSSs emphasizes an evolutionary conservation on the target 




Figure 3.4: Distribution of ZEB2 binding site in proximal TSS regions. (A) 
ZEB2 has a similar distribution across all the chromosomes. In red, 
human; in blue, chimpanzee; in orange, orangutan. Peak height 
corresponds to the peak density in that location. (B) Chromosome 
enrichment of ZEB2 occupancy on 5KB promoter sequence in each 
species. (C) Overlap between ZEB2-bound regions between human, 
chimpanzee, and orangutan. (D) Overlap between genes of ZEB2-bound 







To further understand whether target genes have species-specific 
functions, we analyzed the GO-groups those genes are involved to 
(Methods).  
Interestingly, human specific targets are involved in functions such as 
chromatin organization and remodeling. Such functions have been 
highlighted also in the human-chimpanzee-orangutan common targets. 
Surprisingly, chimpanzee and orangutan are specifically enriched for 
functions such as alternative splicing and transcription respectively, with 
no significant enrichment for categories associated with chromatin states. 
Taken together, this data underlined an evolutionary trajectory of ZEB2 
targets genes involved in chromatin regulation in human lineage.  
Several studies have analyzed the ZEB2 DNA binding specificity at 
individual loci or genes (Verschueren et al. 1999; Gheldof et al. 2012). 
These studies found that ZEB2 protein binding is associated to a zinc 
finger canonical motif (CACCT(G)) that has been experimentally validated. 
But none of these studies analyzed ZEB2 in a genome-wide prospective. 
Thus we further analyzed motif enrichment within the uncovered peaks 
from our experiment. Especially we determined whether selection was 
acting on the cis-regulatory elements bound by ZEB2.  
With de novo motif discovery, we revealed several 9 bp motifs in all the 
primate species analyzed (Methods), similar to the canonical CACCT core 
motif for zinc finger detected in mouse (Verschueren et al. 1999; Comijn et 
al. 2001; Vandewalle et al. 2005). However, we uncovered the 
experimentally described ZEB2 motif only in human peaks, suggesting a 





Figure 3.5: Enrichment of CACCT motif in human peaks. We detected a 
significantly enrichment of ZEB2/1 motif in human peaks whereas 
chimpanzee and orangutan did not show such enrichment. 
 
Besides the significant inter-species similarity in target genes, this data 
provide a first glimpse to the evolution of human ZEB2-bound regions, 
with human specific features compared with other non-human primates. 
Intriguingly, those results are in line with the hypothesis that cis-regulatory 
mutations and changes might play a significant part in the evolution of 
species-specific traits (Wray 2007; Wittkopp and Kalay 2012). Such 
hypothesis has been remarkably confirmed with ZEB1 which showed a 
strong evidence of natural selection in its binding sites (Arbiza et al. 2013), 
suggesting that ZEB2 might have undergone similar evolutionary selection 
in its binding sites. 
    
ZEB2 mediated gene expression 
In order to establish the gene expression changes by loss of ZEB2, we 
performed RNAi-mediated knock down followed by RNA-seq for all the 
LCLs and fibroblast cell lines (Methods). We detected the differentially 
expressed genes (DEGs) in each cell line with shared genes across all the 
replicates of each species (Methods and Fig. 3.6 A). We next asked 
whether the commonly regulated genes have the same direction of 
expression change, detecting 592 human DEGs, 204 chimpanzee DEGs 
and 582 orangutan DEGs (Fig. 3.6 B). Interestingly, we found species-
specific DEGs with a significant overlap between human and chimpanzee 




genes between human and chimpanzee suggests an evolutionary 
convergence of ZEB2 regulatory networks between those two close 
relatives.    
 
 
Figure 3.6: Species-specific differentially expressed genes. (A) Human, 
chimpanzee and orangutan DEGs overlap between replicates. Highlighted 
the number of overlapped genes. (B) Total number of genes that have the 
same trend of expression in at least 2 replicates. (C) Overlap of the filtered 
DEGs in the three species. Human and chimpanzee are significantly 
overlapped, suggesting a ZEB2 functional conservation.  
 
We next combined the genes with peaks detected in the 5KB promoter 
window and the genes differentially regulated, highlighting the most 
confident targets of ZEB2. Among genes with both ChIP-seq peaks and 
gene expressions differences, we found 29 human genes, 29 chimpanzee 
genes, and 94 orangutan genes. Interestingly, only 1 human gene (e.g. 
SLC7A5) and 4 chimpanzee genes (e.g. ZC3H12A, MYC, ARHGDIA, 
DOT1L) are shared with orangutan and none between human and 
chimpanzee. In line with the human specific ZEB2 binding, this data 
emphasize the hypothesis that ZEB2 is more likely to have species-
specific target genes. Nevertheless, our stringent approach might have 
derived only a small subset of genes that are differentially regulated and 




tests and approaches are necessary to understand the complexity of 
ZEB2 transcriptional regulation.     
In human, ZEB2 occupies the regulatory elements near genes 
differentially regulated that are implicated in neurodegenerative and 
psychiatric disorders. For instance, ZEB2 actively regulate MTHFD1L, 
which encodes for an enzyme involved in tetrahydrofolate synthesis in 
embryonic stem cells (Christensen et al. 2005). MTHFD1L is upregulated 
by loss of ZEB2 (log2FC = 0.48) suggesting ZEB2 as repressor of 
MTHFD1L expression. Interestingly, loss and deletion of MTHFD1L are 
associated with abnormal neural tube disorder, characterized by 
exencephaly, embryonic lethality, and craniofacial defects (Momb et al. 
2013; Momb and Appling 2014). Furthermore, knock-down of ZEB2 
reduces the expression of PIP4K2A (log2FC = -0.28), a gene implicated in 
cell proliferation and schizophrenia (Clarke and Irvine 2013; Kaur et al. 
2014; Chan et al. 2015), and LMTK2 (log2FC = - 0.49), a gene coding for 
a membrane kinase implicated in neurodegeneration  (Rattray 2012). 
Together these data indicate that ZEB2 has species-specific target genes 
across multiple great-apes. Furthermore, ZEB2 has a dominant role in 
human specific targets implicated in neurodevelopmental and 




Here, we report our identification of ZEB2 targets genome-widely across 3 
different great-apes, spanning circa 16 myr of evolution. Conservation of 
ZEB2 protein suggests that the sequence/motif of ZEB2 binding sites 
might be conserved across vertebrates (Gheldof et al. 2012).  Our 
interspecies comparison of ZEB2 binding in cell lines from human, 
chimpanzee, and orangutan has revealed over 1400 promoter regions that 
are shared between great-apes, highlighting highly conserved ZEB2 
promoter regions. Despite such ZEB2 occupancy difference, we also 




window) between human, chimpanzee, and orangutan. This data 
demonstrated that the ZEB2 regulatory mechanisms for multiple genes 
are conserved across great-apes. Nevertheless, we also noted multiple 
species-specific ZEB2 targets, suggesting that ZEB2 might have a 
different functions and regulation of species specific targets.  
A recent study suggested that the transcription factor ZEB1 shows the 
strongest evidence of natural selection in its binding site in humans 
(Arbiza et al. 2013). In line with this, our comparative analysis revealed 
species-specific ZEB2 motifs, with a surprising enrichment of the 
CACCT(G) ZEB2 motif only in human linage. This data suggest that not 
only ZEB1 but also ZEB2 binding sites might have undergone a natural 
selection in human compared with other great-apes. 
Human also showed specific peaks in the promoter regions for important 
genes implicated in autism and intellectual disability. For example, ZEB2 
occupancy has been found in promoter regions of human specific 
candidate genes such as CNTN3, CNTN4, EPC2, SETD2 and MP2, 
highlighting the role of ZEB2 in the transcriptional regulation of genes 
implicated in such human specific disorders. Nevertheless, we also found 
ZEB2 binding sites in great-apes conserved targets implicated in brain 
functions such as ADORA3, EGR2, MEF2C, and SMG6. This data is in 
line with the ZEB2 pathways in human brain, suggesting novel candidate 
genes for such neurodevelopment function (Rogers et al. 2013; Buraniqi 
and Moodley 2015; Hegarty et al. 2015). Our ChIP-seq analysis also 
identified peak regions in the TSS of target genes of experimentally 
identified ZEB2-targets. For example, ZEB2 peaks have been found in 
mir200 promoter region in all the three great-apes. Remarkably, ZEB2 is 
known to regulate mir200 during mesenchymal-to-epithelial transition and 
neural induction (Xiong et al. 2012; Du et al. 2013; Wang et al. 2013a). 
Moreover, ZEB2 binding sites have been detected in the promoter region 
of E-cadherin 1 (CDH1) in human, chimpanzee, and orangutan. 
Interestingly, CDH1 is a known target of ZEB2, implicated in cell-cell 
adhesion and neural tube development and defects (Vandewalle et al. 




identification of ZEB2 targets strongly support the functional locations we 
uncovered in this genome-wide multi-species study.      
Due to the transcriptional function of ZEB2 and the lack of functionally 
characterized target genes, we also investigated genes with expression 
that is mediated by reducing ZEB2 expression. In human, we found 
several genes implicated in brain development and functions. For 
instance, we detected upregulation of genes such as SYNGAP1, 
CC2D1A, FMR1, and DEAF1. Interestingly, CC2D1A has been implicated 
in human social skills and intellectual disability (Basel-Vanagaite et al. 
2006; Rogaeva et al. 2007; Manzini et al. 2014). FMR1 is an RNA binding 
protein involved in mRNA stability, trafficking and splicing. FMR1 has been 
also implicated in intellectual disability, affecting the mRNA stability of 
genes important for human cognitive skills and brain development (Devys 
et al. 1993; Brown et al. 2001; Darnell et al. 2011). These data emphasize 
that loss of ZEB2 can affect the transcriptional mechanisms that regulate 
important genes for human cognitive skills. 
We additionally determined whether genes with ZEB2-bound promoter are 
also affected by reducing ZEB2 expression. Interestingly, we found 
several species-specific genes and some of them are really interesting. In 
human, the promoter of MTHFD1L is bound by ZEB2 and MTHFD1L is 
upregulated in decrease of ZEB2. MTHFD1L is a mitochondrial synthetase 
highly expressed during embryogenesis in neural tube and developing 
brain. Lack of MTHFD1L causes aberrant neural tube closure, 
characterized by craniofacial abnormalities and severe exencephaly 
(Christensen et al. 2005; Momb et al. 2013), overlapping with the etiology 
of Mowat-Wilson syndrome (El-Kasti et al. 2012; Buraniqi and Moodley 
2015). We argue that MTHFD1L is directly controlled by ZEB2 in human, 
emphasizing their role in pathways involved in brain development and 
cause severe pathophenotype if affected.   
In summary, ZEB2 bound regions showed highly conserved but also 
species-specific regions, suggesting common and different targets 
controlled by ZEB2 in human, chimpanzee, and orangutan. Among the 




in three great-apes analyzed. We uncovered genes implicated in human 
brain disorder and cognitive skills, emphasizing the implication of ZEB2 in 
brain functions. We also provided a first glimpse of ZEB2 binding site 
evolution, with human specific ZEB2 binding sites. This data supports the 
idea that cis-regulatory elements can drastically vary between closely and 
distantly related species (Wray 2007; Wittkopp and Kalay 2012). In 
addition, we also detected genes whose expression is mediated by 
reducing ZEB2 expression. With this data, we provide novel targets of 
ZEB2, several implicated in neuropsychiatric and neurodevelopmental 
disorders, suggesting the key role of ZEB2 in human brain evolution and 
functions.  
Nevertheless, further characterization how those novel candidate targets 
fit into the ZEB2 regulatory networks must be evaluated. Our analysis is 
limited to cell-types which do not represent a complete tissue or organism. 
Therefore, it is necessary to test such novel ZEB2 targets in different cell-
types or tissues to further confirm what we uncovered with this multi-
species study.  It is also necessary to evaluate whether epigenetic 
mechanisms are affecting the ZEB2 binding in different species.    
However, this study serves as first glimpse to understand the 
transcriptional mechanism controlled by ZEB2 and how those 




Immortalized lymphoblastoid [Corriel instiand fibroblast cell lines were 
obtained for 3 different primate species.  
Lymphoblastoid cell lines were cultured in RPMI 1640 media [Sigma 
Aldrich, cat: R0883] supplemented with 10% fetal bovine serum [Sigma 
Aldrich, cat: F1051], 2mM L-glutamine [Sigma Aldrich, cat: G7513], and 
5000 U/ml Pen/Strep [Sigma Aldrich, cat: P4333]. 
Fibroblast cell lines were cultured in DMEM media [Sigma Aldrich, cat: 




F1051], 2mM L-glutamine [Sigma Aldrich, cat: G7513], 5000 U/ml 
Pen/Strep [Sigma Aldrich, cat: P4333]. 1x108  cells were crossed linked 
with 1% formaldehyde. 
 
ChIP-seq 
The ZEB2 antibody [Sigma Aldrich, cat: AV33694] was used for the 
chromatin-immunoprecipitation. Chromatin-immunoprecipitation protocol 
was adapted according to our conditions. Magnetic beads were used for 
the immunoprecipitation. The immune-precipitated materials were end-
paired, A-tailed, ligated to a single-end sequencing adapter, amplified by 
18 PCR cycle, and size selected (200-300 bp) followed by a single end 
strand specific sequencing on a Illumina genome Analyzer II according to 
the manufacturer’s instructions.   
 
siRNA Design and Knockdown 
Briefly, a total number of three siRNAs sequences targeting ZEB2 
transcripts were manually defined according to multi-species alignment: 
ZEB2-1: 5`- GGCAUAUGGUGACACACAA - 3`   
ZEB2-2: 5`- CUACGUACUUUAAUAGAUU - 3`   
ZEB2-3: 5`- GAACAGACAGGCUUACUUA - 3`   
50nM of siRNAs were transfected with 5ul DharmaFECT lipid transfection 
reagent [LifeScience, cat: T-2001-01] in each cell respectively. RNA was 
extracted after 6 hours with Quiagen RNAeasy kit by following the 
manufacturer’s instructions. For RNA-seq analysis, we used two siRNAs. 
ZEB2 knock-down was confirmed by qPCR.    
Computational methods 
Computational analyses for ChIP-seq and RNA-seq were performed with 
Python and R scripts, using packaged available in Bioconductor.   
 
Read mapping and peak detection 
ChIP-seq and RNA-seq reads from LCL and Fibroblast datasets were 
aligned using segemehl 0.2.0 (Hoffmann et al. 2009)  to the following 




Sequence and genomic annotation were downloaded from UCSC. Aligned 
sequences were filtered for duplicates using Picard toolkit. For ChIP-seq 
analysis, MACS 1.24 (Zhang et al. 2008) was used to detect the high 
enriched peaks after IP. Naked DNA (input) was used as control for the 
FDR cutoff. Peaks were merged across the replicates in each organisms 
using bedtools (Quinlan and Hall 2010), defining a consensus list of peaks 
for each species. Liftover toolkit was used to convert the chimpanzee and 
orangutan coordinated to human hg19, due to the lack of annotation for 
orangutan. Peaks annotation was performed using HOMER (Heinz et al. 
2010).  
For RNA-seq analysis, reads were count using own R scripts. Counts 
were filtered by RPKM > 0.5 in either the control or treatment. For 
differentially expression, we used the DESeq package (Anders and Huber 
2012) and a own R script to detect the differentially expressed genes 
across all replicates. For filtering, we applied a |log2FC| > 0.3 and FDR < 
0.05.   
 
Motif analysis 
To evaluate the motif enriched within the peaks, we used DREME (Bailey 
2011) and XXmotifs (Luehr et al. 2012). Discovered motifs were further 
confirmed using MEME (Bailey et al. 2009). Motifs enrichment were 
additionally compared with ZEB1 ChIP seq using publically available data 




Gene ontology enrichment were performer using FUNC (Prufer et al. 
2007) and additional confirmation with GOstat (Beißbarth and Speed 
2004) and GOrilla (Eden et al. 2009). We report GO groups with 











Summary, conclusions, and 
future perspective 
Although knowledge about TFs is strikingly increasing, most of the TFs 
regulatory mechanisms and cascades remain to be investigated, 
especially with the respect of cell and tissue differences. Recent studies 
have highlighted why TFs are important for cellular states and behavior 
(Neph et al. 2012; Jolma et al. 2013; Bass et al. 2015; Nord et al. 2015), 
but only a paucity of them focused on the evolution of transcriptional 
regulatory mechanisms (Oldham et al. 2006; Nowick et al. 2009; Konopka 
et al. 2012). Such lack of knowledge has driven my interests on the TFs 
and how they are linked with our increased cognitive skills and brain 
functions.  
Transcription factors have been described as key elements in gene 
regulatory networks in multiple species. Moreover, the understanding the 
TF-TF relationships can help to evaluate and uncover potential key 
regulators, contributing to highlight TF that are hubs on the complex 
transcriptional network. Although the advent of large scale experimental 
data such as RNA-seq, DNAase-Seq, and ChIP-seq helped to uncover the 
TF-TF relationships (Neph et al. 2012; Jolma et al. 2013), we are still far 
from understanding the complex transcriptional regulation and circuitry. 
In this PhD thesis, we have developed and implemented a novel approach 
to infer how the TFs interacts, how the TF-TF interactions evolve, which 
TF is a hub, and how a human specific TF-hub has evolved in great apes. 
Hereby, we first summarize the results, describing the three chapter of the 






TF-TF relationships by co-expression 
There is very little known behind the regulatory mechanisms the TF are 
implicated to. As mentioned, one of the main limitations is due to the 
experimental procedures that are directed to single TFs in a single cell-
type or tissue. Furthermore, such approaches are also limited to the 
affinity of the antibody or reagents, to the chromatin state of that particular 
cell or tissue, and the different activity of TFs in a particular cellular state.  
Nevertheless, TF regulatory networks have been implicated in several 
aspect of the cell such as chromatin and epigenetic states, imprinting a 
particular “memory” to a cell that will affect the subsequent fate. Hence, 
TF circuitries of a specific cell type or tissue are often involved in 
development (Davidson et al. 2002; Neph et al. 2012; Nord et al. 2015; 
Shibata et al. 2015), pluripotency (Chen et al. 2008; Kim et al. 2008; 
Kushwaha et al. 2015; Lopez-Pajares et al. 2015), cell differentiation (Lin 
et al. 1996; Somasundaram et al. 2015), regulating the expression of 
genes implicated in such pathways. 
Despite the important function of the TFs in development and gene 
regulation, the TFs circuitries are presently poorly characterized, lacking 
information on interactions and experimentally confirmed pathways.   
Due to those several limitations, we sought here to develop approached to 
statistically analyze the TFs co-expression networks in multiple tissues 
and species, highlighting the power of co-expression networks from 
genome-wide expression data.  
As previously described, the first chapter evaluated the TF-TF interactions 
on expression data and showed which interactions are conserved across 
primate species and which interactions have changed species-specifically. 
The interactions were inferred based on a wTO method specifically 
developed for TFs and are suitable for any cellular and tissue state the 
genome-wide expression data is based on.  
The networks we described in the first chapter for the three primate 
species provide an extensive description of TF regulatory mechanisms 




conservation and gain-or-loss of TF-TF interactions. By an inter-species 
filtering, we provide an extensive description of the TF circuitry evolution in 
PFC, a brain region strongly associated with human specific skills and 
cognitive abilities. We also provided an inference of ancestral network, 
pointing out which TF-TF interactions are based on identical trend of 
correlation between three species. This allowed us to detect not only 
species-specific links but also such TF-TF interactions that are strikingly 
conserved in primate evolution. Such inter-species approach has 
uncovered novel and well-characterized TF-TF interactions, some of them 
really interesting. For instance, MEF2C is a TF implicated in memory 
formation, synaptic plasticity, and several disorders such as autism and 
intellectual disability (Lin et al. 1996; Flavell et al. 2008; Novara et al. 
2010; Saitsu et al. 2011). In the provided TF networks, MEF2C interacts 
with HIRA, implicated in neural crest cell migration and DiGeorge 
syndrome (Wilming et al. 1997; Magnaghi et al. 1998) and HDAC9, a 
histone deacetylase involved in developing brain and autism (Sugo et al. 
2010; Pinto et al. 2014). Such interactions are strongly conserved in 
human and chimpanzee lineage but not in rhesus macaque, emphasizing 
an evolutionary trajectory of such TF-TF interaction in great apes. 
Furthermore, those interactions have been experimentally characterized in 
other tissues (Haberland et al. 2007; Yang et al. 2011), providing novel 
pathway and role of such TF-TF interactions in PFC.  
We also observed that human networks often have higher connectivity 
compared with the other non-human primates, highlighting a rapid gain of 
links in the human lineage. Another striking observation is the difference in 
connectivity between tissues. Remarkably, we found that TF circuitry have 
higher connectivity in brain tissues compare with kidney and muscle. 
Remarkably, human showed higher connectivity compared with 
chimpanzee in all the brain regions analyzed.  
In addition, using the expression changes, we have provided another 
important approach to mine such genome-wide expression data from adult 
and developing PFC. Briefly, we defined the TF-TF interactions using a 




positive correlation between TF and gene both up or down regulated in 
human. On the other hand, we considered only negative correlation where 
TF and genes have opposite species-specific expression. We called the 
resulting networks EC-sub-networks and we defined only the TF-TF 
interactions where TFs can act as activator (TF up – positive correlation – 
Gene up) or repressor (TF up – negative correlation – Gene down) of 
gene expression. We observed a strong gain of interactions in the human 
EC-sub-networks compared with chimpanzee EC-sub-networks. 
Furthermore, human networks are uniquely enriched for such TF 
important for brain functions (brain-TFs), such as CLOCK, ZNF536, 
CC2D1A emphasizing the role of such TFs in TF circuitry that might be 
involved on human brain functions and disorders. 
Although the network evolution and EC-sub-networks highlighted several 
“Brain-TF” significantly enriched in the human PFC networks, it is currently 
unclear whether such “brain-TFs” are “master regulators” of human PFC 
gene regulatory mechanisms. 
To answer this question, in the second chapter we provided a high-
confidence human frontal lobe consensus network to further identify and 
analyze TFs with potential implications in cognitive skills and disorders.  
The consensus network is based on merely 2516 interactions between 
TFs across 10 different genome-wide expression studies of human frontal 
lobe, emphasizing differences derived by single and independent data. 
Moreover, in this particular study, we aimed to integrate such brain-TFs 
and understand whether they have a central role in the consensus 
network. To answer this question, we assembled a list of TFs important for 
brain function, development, and disorders, screening multiple 
independent sources. In total, we found 515 brain-TFs. In addition, we 
catalogued the TFs that are targeted by FMRP, important RNA binding 
protein implicated in intellectual disability (Darnell et al. 2011), detecting 
120 additional TFs.  
Interestingly, brain-TFs are enriched in the consensus network and they 
have an overall higher connectivity compared with the other TFs, 




found that brain-TFs are remarkably crucial for the TF circuitry architecture 
during frontal lobe fetal development compared with adult, underlining 
what we previously suggested with the human developmental PFC 
network. The consensus network provided novel pathways in which brain-
TFs might be involved. For instance, we found that MEF2C is strongly 
associated with other brain-TFs such as ZNF711, SOX11, SOX5, and 
PBX1. Interestingly, MEF2C is known to interact with SOX transcription 
factors family members to activate neurons during development (Chan et 
al. 2015). Moreover PBX1 is differentially expressed after MEF2C-shRNA 
mediated knock down (Chan et al. 2015). We therefore argued that 
MEF2C and the features of the brain-TFs in human frontal lobe consensus 
network might be implicated in such regulatory pathways that control brain 
and cognitive functions. Since we found that brain-TFs are important for 
the human PFC circuitry and evolution, the consensus network further 
confirm the central role of such TFs in circuitry and regulation of human 
frontal lobe.  
The examples provided in this thesis showed how the TF circuitries are 
important in brain tissues, particularly the human PFC, and how TF 
interactions are conserved or evolved lineage-specifically. We also 
provide a first glimpse of the brain-TFs as central hub of the TF circuitries 
in human PFC networks. The drastic enrichment of brain-TFs connectivity 
provides a novel function of such TFs in the gene regulatory mechanisms. 
Thus, we hypothesized that such complex regulatory mechanisms and 
pathways controlled by brain-TFs might be remarkably implicated in the 
human cognitive skills and disorders. 
 
ZEB2: a transcription factor important for human 
brain evolution and functions.  
In the first two chapters, we described network and system level 
frameworks to infer how TFs have contributed to the evolution of cognitive 




biological networks, we determined TFs that gained species-specific links 
and TFs that are central hub in the TF circuitries. Thus, such approaches 
offered a relatively big picture of the TF regulatory networks, pointing out 
several candidates for human PFC functions. However, for many TFs it is 
still not understood the complex transcriptional mechanisms they control, 
lacking on experimentally validated target genes and pathways. For 
instance, several brain-TFs have been implicated in a patho-phenotype by 
single nucleotide polymorphisms or de novo mutations (Ravassard et al. 
1999; Basel-Vanagaite et al. 2006; De Rubeis et al. 2014). Therefore, 
ChIP-seq and other NGS technologies such as DNAaseI footprints are 
necessary to further provide functional targets of brain-TFs that are central 
node in TF networks, emphasizing their role in the regulation of important 
brain pathways. 
Nevertheless, one of the current bottlenecks in studying transcriptional 
networks is that prediction from such hub detection using network biology 
level (Oldham et al. 2006; Nowick et al. 2009; Konopka et al. 2012; 
Parikshak et al. 2013; Bakken et al. 2015) are generally dissociated from 
further experimental evaluation.     
To fill the gap between network biology predictions and experimental level, 
in the third chapter we aimed to functionally characterized one of the most 
interesting TF, ZEB2, that gained a significant number of links in human 
specific PFC network compared with chimpanzee (Nowick et al. 2009). 
Such ZEB2 human specific enriched interactions emphasize pathways 
that might have shaped such cognitive skills linked with PFC.  
ZEB2 is a TF member of the ZEB family that plays an important role in the 
development of mammalian embryos (Goossens et al. 2011). Such 
function is directed to the formation and characterization of the neural 
cress cells, in which ZEB2 transcriptional program is implicated in 
migration and cellular fate (Vandewalle et al. 2005; Vandewalle et al. 
2009; Goossens et al. 2011; Ohayon et al. 2015). ZEB2 is a complex 
transcription factor, consisting in two clusters of C2H2-type zinc finger 
domains with a central homeodomain. It is known that ZEB2 repressed 




separated E-box-like sequences (CACCT(G)/CACCANNT(G)) while the 
homeodomain is thought to be responsible for protein-protein interactions 
(Verschueren et al. 1999; Comijn et al. 2001; Gheldof et al. 2012). Such 
ZEB2 zinc finger have a high degree of sequence similarity (circa 90%) 
with ZEB1, paralogs of ZEB2, suggesting their similar binding affinity to 
the DNA (Gheldof et al. 2012). ZEB2 is known to interact with SMADs 
transcription factors by the SDB domain, regulating in the TGF(Beta) 
signaling pathway, important for nervous system development, specifically 
in neural tube and neural crest (Xiong et al. 2012; Hegarty et al. 2015). 
Another important aspect of ZEB2 is its implication in Mowat-Wilson 
syndrome, a sever disorder characterized by microcephaly, intellectual 
disability, and facial malformations (Cecconi et al. 2008; El-Kasti et al. 
2012; Evans et al. 2012; Buraniqi and Moodley 2015).  
Nevertheless, the regulatory program controlled by ZEB2 is still far-
understood, lacking in specific target and evolutionary trajectory of the 
binding sites. Therefore, we aimed to functionally characterized ZEB2, 
using multiple primate species and evaluate the evolutionary pressure in 
the cis-regulatory elements bound by ZEB2. Using recent NGS 
technologies as ChIP-seq and RNA-seq, we have been capable to 
uncover the ZEB2 target genes in human, chimpanzee, and orangutan 
biological replicates of LCLs and fibroblasts, spanning circa 16 million 
years of evolution.  
Interestingly, we identified several ZEB2-bound regions that are shared 
and species-specific between great-apes at chromosomal and gene 
levels. Such shared regions highlighted great-apes common genes with 
ZEB2 occupancy in the promoter regions implicated in histone 
modification and plasticity. Intriguingly, human specific targets showed a 
similar enriched function, suggesting an evolutionary trajectory in human 
lineage. Interestingly, histone modification and plasticity have been linked 
to several human specific cognitive skills such as memory, social 
behavior, and emotions (Levenson et al. 2004; Guan et al. 2009; 
McQuown et al. 2011; Peixoto and Abel 2013), underlining the ZEB2 




Nowick et al. 2009; Buraniqi and Moodley 2015; Hegarty et al. 2015). 
Furthermore, the human lineage trajectory has been emphasized also at 
TFBS level, with a human specific enrichment of CACCT(G) known ZEB2 
motif. Thus, we speculated that such trajectory might be caused by cis-
regulatory difference in the binding sites between human and other great-
apes, confirming the potential role of ZEB2 in human evolution. 
Combining the ChIP-seq and the siRNA knock down followed by RNA-
seq, we further defined ZEB2 targets that are also differentially regulated 
by decrease of ZEB2 protein expression. Using this approach, we have 
been able to functionally characterized novel putative and high confident 
target of ZEB2. Among those, we identified MTHFD1L, a human specific 
down-regulated target of ZEB2. Interestingly, MTHFD1L is associated with 
a human sever brain disorder, characterized by exencephaly, craniofacial 
abnormalities, and neural tube defects. Due to the significant overlap 
between Mowat-Wilson syndrome and MTHFD1L patho-phenotypes, we 
argued that ZEB2-MTHFD1L interplay is strongly linked with human brain 
development and functions.     
In summary, this is the first known quantitative and qualitative evolutionary 
analysis of ZEB2 that identified gain or loss targets during great-apes 
evolution. Moreover, this data emphasize the role of ZEB2 in brain 
development, detecting novel and well-characterized targets that are 
implicated in brain function and disorder. This project has remarkably 
contributed to understand the potential implication of TFs in human brain 








Outlook and future 
directions 
The importance of species specific TFs as master regulators of cell and 
tissue molecular pathways has rapidly increased in the past decades. 
Several studies and consortiums have made remarkable advance to 
functionally characterizing and cataloguing specific TFs (Consortium 2004; 
Neph et al. 2012; Jolma et al. 2013; Wang et al. 2013b). Nevertheless, the 
majority of TFs (circa 96%) remains mostly uncharacterized (Chawla et al. 
2013; Mathelier et al. 2013), driving the TF research field to develop novel 
tools and methods to functionally curate such important key regulators. 
Because of that, with this thesis we contributed to understand the function 
of such TFs in the human frontal lobe, a region strongly linked with our 
cognitive abilities and disorders (Koechlin et al. 2003; Ecker et al. 2012; 
Donoso et al. 2014; Domenech and Koechlin 2015). Those projects 
provided a detailed glimpse of how the TF networks are implicated in 
human brain functions and how a specific TF is an important regulator of 
genes implicated in neurodevelopment and disorders. Nevertheless, we 
are still far to understand the complexity of TF networks in the regulation 
of specific phenotypes. Hence, the next step is to apply such detailed 
methods to different tissue and cells to further analyze the role of TFs in 
determined tissue. Using the wTO approach, we might define TF circuitry 
implicated in other brain regions, neurons, or glia cells, emphasizing the 
different role of TF in specific cells or tissues.  Furthermore, due to the 
lack of functionally characterized TFs (such as KRAB-ZNF), it is important 
to continue the functional characterization of TFs by specific bioinformatics 
methods. Those approaches serve to determine which TFs play an 
important biological role in the TF network (e.g. hubs) and experimental 
verify such function in the laboratory. For this, it is necessary to study TFs 




potential implications of the candidate TFs in determining phenotypes, e.g. 
behavior. My academic career focus will be on the evolution of TFs and 
the relationship between TF regulation and phenotype in a neuroscience 
perspective. I aim to study TFs involved in behavior and cognitive skills, 
such as CLOCK and FOXP1, to identify using NGS technologies the 
transcriptional mechanisms that are regulated by those important TFs and 
moreover their function in brain regions. In the end, this thesis highlighted 
not only the important role of TFs in brain development but also the power 








Figure S1.1:  “Leave-one-out” methods shown by the Euclidian distance 
represented in two dimensional scaling plot. In red the human individuals, 
in blue the chimpanzee individuals and in green the rhesus macaque. The 
“leave-one-out” methods demonstrate the observed species difference is 
robust and the individuals are clustering according to the Euclidian 









Figure S1.2: Brain-TF degree enrichment per brain region and other tissue. H corresponds to human, C corresponds to 
chimpanzee, and R corresponds to rhesus macaque. Zscore showed the connectivity for each TF in each region (red = 
high, blue = low). Most of the Brain-TFs have a higher connectivity in brain regions emphasizing their role in brain 









Figure S1.3: Human networks gene ontology enrichment from adult samples. Circle size corresponds to the p-value after 
FDR correction. Human PFC showed an interesting enrichment pattern of brain related categories compared with other 
regions, suggesting the TF circuitry might be related to such important brain specific mechanisms.  
 
 
Figure S1.4:  Lineage “Brain TF” modules. On the top part, the adult EC-sub-network and on the bottom, the 




corresponds to the hub function of a TF. Human showed an enrichment of “Brain TFs” interactions compared with 
chimpanzee. Several TF-TF interactions are confirmed in both human “Brain TFs” modules, suggesting that such 





Figure S1.5: Degree distribution in the human EC-sub-networks. Zscore showed the connectivity for the developmental 
and adult PFC (red = high, blue = low). Several TFs maintained their connectivity in different data while other TFs 
changed drastically their connectivity. This is potentially linked with the function of some TF throughout development. 






Figure S1.6: Degree distribution in the chimpanzee EC-sub-networks. Zscore showed the connectivity for the 
developmental and adult PFC (red = high, blue = low/not present). Again, chimpanzees specific TFs maintained the 
connectivity in different stages of PFC development. However, several TFs changed drastically. ZNF-TFs showed a 







































Table S1.1: Census of the transcription factors involved in brain function and disorder 
 
Gene symbol FMRP targets Association 
AATF  Chromosome 17q12 microdeletion syndrome 
ABCA2 FMRP Alzheimer's disease 
ABCG1 FMRP Alzheimer's disease 
ADNP FMRP Autism, Brain Development 
ADORA2A  Autism 
ADRB2  Autism, Alzheimer's disease 
AEBP2  Brain Development 
AFF2  Autism, Intellectual Disability, Mental retardation, X-linked, FRAXE type 
AFF3 FMRP  
AFF4 FMRP Autism 
AHDC1 FMRP  
AKAP9 FMRP  
ALX1  Frontonasal dysplasia 2 
ALX3  Frontonasal dysplasia 2 
ALX4  Frontonasal dysplasia 2 
ANP32A  Spinocerebellar ataxia 
APBB1 FMRP  
APBB2  Alzheimer's disease 
APC FMRP Autism, Schizophrenia, Parkinsons's disease 
APP FMRP Autism, Alzheimer's disease 
APTX  Intellectual Disability 




ARHGEF11 FMRP  
ARID1A FMRP Mental retardation, autosomal dominant 14 (ID) 
ARID1B FMRP Autism, Mental retardation, autosomal dominant 12 (ID) 
ARID2 FMRP  
ARID5B  Alzheimer's disease 
ARNT2 FMRP Autism 
ARNTL  Circadian rythm, Bipolar disorder 
ARNTL2  Circadian rythm, Bipolar disorder 
ARRB1 FMRP  
ARX  Autism, Intellectual Disability, Autism, Lissencephaly, Hydranencephaly, Epilepsy, Mental retardation X-linked 
ASB11  Brain Development 
ASCL1  Intellectual Disability, Brain Development 
ASH1L FMRP  
ASXL1  Bohring-Opitz syndrome 
ATF2  Brain Development 
ATF4  Brain Development 
ATF5  Brain Development 
ATF7  Alzheimer's disease 
ATF7IP FMRP  
ATM  Schizophrenia, Ataxia-telangiectasia 
ATMIN FMRP  
ATN1 FMRP Intellectual Disability 
ATOH1  Brain Development 
ATRX  Intellectual Disability, Mental retardation-hypotonic facies syndrome, X-linked, Autism 
ATXN1 FMRP Alzheimer's disease, Spinocerebellar ataxia 1 




ATXN7  Autism, Spinocerebellar ataxia 7 
BARHL1  Joubert syndrome, Brain Development 
BAZ1B  Williams-Beuren syndrome 
BAZ2A FMRP  
BCL11A  Brain Development 
BCL2  Autism 
BCL9L FMRP  
BCOR  Intellectual Disability, Microphthalmia, syndromic 2 
BEX1  Brain Development 
BHLHA9  Miller-Dieker lissencephaly syndrome 
BIN1  Autism, Alzheimer's disease 
BMP4  Microphthalmia, syndromic 6 
BMP6  Schizophrenia 
BPTF FMRP  
BRCA2  Autism 
BRD1  Schizophrenia 
BRD2  Juvenile myoclonic epilepsy 
BRD4 FMRP  
BSX  Jacobsen syndrome 
BTAF1  Autism 
BTBD6  Chromosome 14q32.3 deletion syndrome 
CAMKK2 FMRP  
CAMTA1 FMRP Autism, Cerebellar ataxia, nonprogressive, with mental retardation 
CAMTA2 FMRP  
CAND1 FMRP  




CBL  Noonan syndrome 
CBX6 FMRP  
CC2D1A  Intellectual Disability, Mental retardation, autosomal recessive 3 
CDK5  Alzheimer's disease, Parkinson's disease 
CDK8  Intellectual Disability 
CDKN1B  Autism 
CDKN1C  Beckwith-Wiedemann syndrome 
CDX2  Alzheimer's disease 
CHD2  Autism, Epileptic encephalopathy 
CHD3 FMRP  
CHD4 FMRP  
CHD5 FMRP  
CHD6 FMRP Pitt-Hopkins syndrome 
CHD7  Intellectual Disability, CHARGE syndrome, Autism 
CHD8 FMRP Autism 
CHMP1A  Pontocerebellar hypoplasia, type 8 
CIC FMRP  
CLOCK  Circadian rythm, Bipolar disorder, Schizophrenia 
CNBP  Myotonic dystrophy 2 
COIL  Brain Development 
COPS3  Smith-Magenis syndrome 
CREBBP FMRP Intellectual Disability, Autism, Rubinstein-Taybi syndrome 
CREM  Panic Disorder 
CRTC1 FMRP  
CRY1  Circadian rythm, Bipolar disorder 




CTBP1 FMRP  
CTCF  Autism, Mental retardation, autosomal dominant 21 (ID) 
CTDP1  Intellectual Disability, Congenital cataracts, facial dysmorphism, and neuropathy 
CTNNB1 FMRP Autism, Mental retardation, autosomal dominant 19 (ID) 
CTNND2 FMRP  
CUL2  Parkinson's Disease 
CUL3  Autism 
CUL4B  Intellectual Disability, Mental retardation, X-linked, syndromic 15 
CUX1 FMRP  
CUX2 FMRP Bipolar disorder 
DBX1  Brain Development 
DBX2  Brain Development 
DEAF1  Autism, Mental retardation, autosomal dominant 24 (ID) 
DEPDC5  Autism, Epilepsy, familial focal, with variable foci 
DIDO1 FMRP  
DIP2C FMRP  
DLX1  Autism, Schizophrenia 
DLX2  Autism 
DLX5  Rett syndrome, Brain Development 
DLX6  Autism, Rett syndrome 
DNMT1  Neuropathy, hereditary sensory, type IE 
DNMT3A  Tatton-Brown-Rahman syndrome 
DNMT3B  Schizophrenia 
DOT1L FMRP  
DTX1 FMRP Brain Development 




DVL1  Alzheimer's disease 
EBF3  Alzheimer's disease, Schizophrenia 
EGF  Schizophrenia 
EGR1 FMRP Brain Development 
EGR2  Autism 
EGR3  Schizophrenia 
EGR4  Schizophrenia 
EHMT1 FMRP Autism, Kleefstra syndrome, Intellectual Disability 
EHMT2 FMRP  
ELF1  Brain Development 
EMX1  Brain Development 
EMX2  Intellectual Disability, Schizencephaly 
EN1  Parkinson's disease 
EN2  Autism, Parkinson's disease 
ENC1 FMRP Brain Development 
EOMES  Microcephaly 
EP300 FMRP Autism, Intellectual Disability, Rubinstein-Taybi syndrome 2 
EP400 FMRP Autism 
EPC2  Autism, Alzheimer's disease 
ERBB2  Autism 
ERBB4  Autism, Brain Development 
ERCC2  Intellectual Disability, Cerebrooculofacioskeletal syndrome 2, Trichothiodystrophy 
ERCC3  Intellectual Disability 
ERCC6  Cerebrooculofacioskeletal syndrome 1, Cockayne syndrome, type B, De Sanctis-Cacchione syndrome 
ERCC8  Cockayne syndrome, type A 




ESR1  Autism, Alzheimer's disease, Parkinson's disease 
ESR2  Autism, Parkinson's disease 
ESRRB  Autism 
ETV1  Brain Development 
FAM171B FMRP  
FBN1  Intellectual Disability 
FBXL19 FMRP  
FBXO41 FMRP  
FBXO7  Parkinson's Disease 
FEZF1  Brain Development 
FEZF2  Autism, Brain Development 
FGD1  Autism, Intellectual Disability, Aarskog-Scott syndrome , Mental retardation, X-linked syndromic 16 
FLNA  Intellectual Disability, Brain Development 
FMR1  Intellectual Disability, Autsim, Fragile X syndrome 
FOS  Alzheimer's disease 
FOXF2  Chromosome 6pter-p24 deletion syndrome 
FOXG1  Intellectual Disability, Autism, Rett syndrome 
FOXK2 FMRP  
FOXO1  Brain Development 
FOXO3 FMRP  
FOXP1  Autism, Intellectual Disability, Autism, Mental retardation with language impairment 
FOXP2  Autism, Brain Development 
FOXP4  Brain Development 
FOXQ1  Ritscher-Schinzel syndrome 
FRY FMRP  




FXR1  Mental Retardation, Fragile X syndromic (ID) 
FXR2  Mental Retardation, Fragile X syndromic (ID) 
GAS7 FMRP Brain Development 
GATAD2B  Mental retardation, autosomal dominant 18 (ID) 
GLI2  Intellectual Disability, Holoprosencephaly 
GLI3  Intellectual Disability, Greig cephalopolysyndactyly syndrome 
GON4L  Intellectual Disability 
GPR123  Brain Development 
GSX1  Brain Development 
GSX2  Brain Development 
GTF2I  Autism 
GTF2IRD2  Williams-Beuren syndrome 
GTF2IRD2B  Williams-Beuren syndrome 
GTF3C1 FMRP  
GTF3C2 FMRP  
HAX1  Kostmann syndrome 
HCFC1 FMRP Autism, Intellectual Disability 
HDAC1  Brain Development 
HDAC2  Brain Development 
HDAC3  Brain Development 
HDAC4 FMRP Autism, Schizophrenia, Brachydactyly-mental retardation syndrome, Brain Development 
HDAC5 FMRP  
HDAC6  Autism, Brain Development 
HDAC8  Intellectual Disability 
HES6  Brain Development 




HEYL  Brain Development 
HHEX  Alzheimer's disease 
HIC1  Miller-Dieker lissencephaly syndrome 
HIC2  DiGeorge syndrome 
HIPK1 FMRP  
HIPK2 FMRP  
HIPK3 FMRP  
HIST1H2BJ  Schizophrenia 
HIVEP1 FMRP  
HIVEP2 FMRP  
HIVEP3 FMRP  
HLA-DRB1  Autism 
HLF  Brain Development 
HMGB3  Microphthalmia, syndromic 13 
HMGN1  Autism 
HMGXB3 FMRP  
HMX2  Brain Development 
HMX3  Brain Development 
HNRNPH2  Autism 
HNRNPUL1 FMRP  
HOXA1  Autism, Intellectual Disability, Autism, Bosley-Salih-Alorainy syndrome 
HOXB1  Autism 
HOXD1  Chromosome 2q32-q33 deletion syndrome 
HOXD10  Brain Development 
HOXD11  Autism 




HOXD13  Autism 
HOXD3  Brain Development 
HOXD4  Brain Development 
HOXD9  Brain Development 
HTT FMRP Huntington Disease 
IFNG  Schizophrenia 
IKBKG  Intellectual Disability 
IL6  Alzheimer's disease 
IRX5  Hamamy syndrome 
JARID1C  Mental retardation, X-linked (ID) 
JARID2  Autism 
JMJD1C  Autism 
KAT6B  SBBYSS syndrome 
KAT8  Koolen-De Vries syndrome 
KCNH1 FMRP  
KCNH2  Schizophrenia 
KCNH3 FMRP  
KCNH7 FMRP  
KCNIP1  Brain Development 
KDM1A  Brain Development 
KDM4B FMRP  
KDM5B  Autism 
KDM5C FMRP Autism, Intellectual Disability 
KHDRBS1  Brain Development 
KHDRBS2  Autism 




KLF13  Chromosome 15q13.3 deletion syndrome 
KLF5  Alzheimer's disease, Schizophrenia 
KLF6  Schizophrenia 
KLF7  Brain Development 
KLF8  Intellectual Disability 
LARP7  Intellectual Disability, Alazami syndrome 
LAS1L  Intellectual Disability 
LBX1  Brain Development 
LBX2  Brain Development 
LHX1  Chromosome 17q12 deletion syndrome 
LHX2  Brain Development 
LHX3  Pituitary hormone deficiency, combined, 3 
LHX4  Pituitary hormone deficiency, combined, 3 
LHX6  Brain Development 
LHX8  Brain Development 
LHX9  Brain Development 
LMX1A  Schizophrenia, Brain Development 
LMX1B  Autism, Schizophrenia 
LRPPRC  Autism, Leigh syndrome, Intellectual Disability 
MACF1 FMRP  
MAFB  Multicentric carpotarsal osteolysis syndrome 
MAFK  Brain Development 
MAGED1 FMRP Autism, Brain Development 
MAPK1 FMRP Autism 
MAPK14  Schizophrenia 




MAZ FMRP  
MBD1  Autism 
MBD2  Rett syndrome 
MBD3  Autism 
MBD4  Autism 
MBD5 FMRP Autism 
MBD6  Autism 
MBNL1  Myotonic dystrophy 1 
MBNL2  Myotonic dystrophy 1 
MBNL3  Myotonic dystrophy 1 
MECP2  Intellectual Disability, Autism, Rett syndrome 
MED12  Intellectual Disability, Lujan-Fryns syndrome, Ohdo syndrome, Opitz-Kaveggia syndrome, Autism 
MED13 FMRP  
MED13L FMRP  
MED14 FMRP  
MED16 FMRP  
MED17  Microcephaly, postnatal progressive, with seizures and brain atrophy 
MED23  Mental retardation, autosomal recessive 18 (ID) 
MEF2A  Brain Development, Alzheimer's disease 
MEF2C  Autism, Chromosome 5q14.3 deletion syndrome, Mental retardation (ID), stereotypic movements, epilepsy, and/or cerebral malformations 
MEF2D FMRP Brain Development, Parkinson's disease 
MEFV  Alzheimer's disease 
MEIS2  Brain Development 
MEOX2  Alzheimer's disease 
MET  Autism 




MID2  Intellectual Disability 
MINK1 FMRP  
MITF  Autism 
MKL2 FMRP Autism 
MLL FMRP Brain Development 
MLL2 FMRP Kabuki syndrome 1 
MLL3 FMRP  
MLLT3  Brain Development 
MNT  Miller-Dieker lissencephaly syndrome 
MPRIP FMRP  
MTF1  Autism 
MYCBP2 FMRP  
MYCN  Intellectual Disability, Feingold syndrome 
MYRF  Brain Development 
MYT1L FMRP Autism, Intellectual Disability 
NAA15  Autism 
NAP1L2  Brain Development 
NCALD  Brain Development 
NCOA1 FMRP  
NCOA2 FMRP  
NCOA6 FMRP  
NCOR1 FMRP  
NCOR2 FMRP  
NCS1 FMRP Brain Development 
NDN  Prader-Willi syndrome 




NEUROD1  Brain Development 
NEUROD2  Brain Development 
NEUROD4  Brain Development 
NEUROD6  Brain Development 
NEUROG1  Brain Development 
NEUROG2  Brain Development 
NEUROG3  Brain Development 
NFATC3  Brain Development 
NFATC4  Brain Development 
NFIA  Autism 
NFIB  Brain Development 
NFIC FMRP  
NFIX FMRP Marshall-Smith syndrome, Sotos syndrome 
NFKB1  Brain Development 
NKX2-1  Intellectual Disability, Brain Development 
NKX2-2  Brain Development 
NOP2  Mental retardation, autosomal recessive 5 (ID) 
NOTCH4  Schizophrenia 
NPAS2 FMRP Autism, Circadian rythm, Schizophrenia, Bipolar disorder 
NPAS3  Schizophrenia, Brain Development 
NPAS4  Brain Development 
NR1D1  Circadian rythm, Bipolar disorder 
NR1D2  Circadian rythm 
NR2E1  Brain Development 
NR2F1 FMRP  




NR3C1  Brain Development 
NR3C2  Autism 
NR4A2  Brain Development 
NR4A3  Brain Development 
NRG1  Schizophrenia, Brain Development 
NRIP1 FMRP  
NSD1 FMRP Autism, Intellectual Disability, Sotos syndrome 
NUFIP1  Brain Development 
OLIG1  Brain Development 
OLIG2  Brain Development 
OLIG3  Brain Development 
OTX1  Autism 
OTX2  Microphthalmia, syndromic 5 
PARP1  Intellectual Disability, Alzheimer's disease 
PAWR  Schizophrenia 
PAX1  Otofaciocervical syndrome 2 
PAX2  Brain Development 
PAX3  Brain Development 
PAX5  Brain Development 
PAX6  Brain Development 
PAX7  Brain Development 
PAX8  Intellectual Disability 
PAXIP1  Alzheimer's disease 
PBX1  Brain Development 
PCNA  Ataxia-telangiectasia-like disorder 




PDLIM5  Bipolar disorder 
PDS5B FMRP  
PEG3 FMRP  
PER1 FMRP Autism, Brain Development, Circadian rythm 
PER2  Circadian rythm 
PER3  Circadian rythm 
PEX14  Zellweger Syndrome 
PHC1  Brain Development, Microcephaly 
PHF12 FMRP  
PHF2  Autism 
PHF20 FMRP  
PHF6  Borjeson-Forssman-Lehmann syndrome 
PHF8  Autism, Intellectual Disability, Mental retardation syndrome, X-linked, Siderius type 
PHOX2B  Central hypoventilation syndrome, congenital, with or without Hirschsprung disease 
PICALM  Alzheimer's disease 
PIKFYVE FMRP  
PITX1  Autism 
PITX3  Schizophrenia, Brain Development 
PKN1  Brain Development 
PLXNA1 FMRP Brain Development 
PLXNA2 FMRP Brain Development, Schizophrenia 
PLXNA3  Brain Development 
PLXNB1 FMRP Brain Development 
PLXNB2  Brain Development 
PLXNB3  Brain Development 




POGZ  Autism 
POLR2A FMRP  
POLR3B  Intellectual Disability 
POU1F1  Intellectual Disability 
POU3F1  Brain Development 
POU3F2  Brain Development 
POU3F3  Brain Development 
POU3F4  Brain Development 
POU4F1  Brain Development 
POU4F3  Brain Development 
PPARD  Schizophrenia, Brain Development 
PPARG  Schizophrenia, Alzheimer's disease 
PPARGC1A FMRP  
PPP2R1A FMRP  
PQBP1  Intellectual Disability, Renpenning syndrome 
PREX1 FMRP  
PREX2 FMRP  
PRR12 FMRP  
PRRX1  Holoprosencephaly-Agnathia 
PTCH1 FMRP Holoprosencephaly, Intellectual Disability 
PTCHD1  Autism, Intellectual Disability 
PTEN FMRP Intellectual Disability, Autism, Cowden syndrome 
PTGER3  Autism 
PURA  Brain Development 
RAB18  Warburg micro syndrome 3 




RAI1  Intellectual Disability, Autism, Smith-Magnis syndrome 
RAPGEF4 FMRP Autism 
RARB  Brain Development 
RAX  Brain Development 
RB1CC1  Autism 
RBBP8  Jawad syndrome, Seckel syndrome 2 
RBM10  Intellectual Disability 
RBPJ  Adams-Oliver syndrome 3 
RC3H1 FMRP  
RC3H2 FMRP  
RCAN1  Brain Development 
RCOR1  Brain Development 
RERE FMRP Autism 
REST  Brain Development 
RFC1  Alzheimer's disease 
RFPL3  Brain Development 
RFX4  Brain Development 
RGS6  Alzheimer's disease 
RGS7  Intellectual Disability, Brain Development, Autism 
RHOXF1  Autism 
RIMS3  Autism 
RNF112  Alzheimer's disease 
RNF135  Overgrowth syndrome 
RNPS1  Autism 
RORA  Autism 




RUFY3  Brain Development 
RUNX1  Alzheimer's disease 
RUNX2  Cleidocranial dysplasia 
RXRA  Alzheimer's disease 
RYBP  Brain Development 
SALL1  Intellectual Disability, Townes-Brocks syndrome 
SALL2 FMRP  
SAMD4B FMRP  
SAP130 FMRP  
SATB1  Brain Development 
SATB2  Autism, Intellectual Disability, Brain Development, Cleft palate and mental retardation 
SCAF1 FMRP  
SCAPER  Intellectual Disability 
SETBP1  Intellectual Disability, Schinzel-Giedion midface retraction syndrome 
SETD1A  Schizophrenia 
SETD2  Autism 
SETDB1  Autism, Huntington disease 
SETDB2  Autism 
SHH  Intellectual Disability, Holoprosencephaly, Schizencephaly 
SIRT1  Schizophrenia 
SIRT5  Schizophrenia 
SIX3  Holoprosencephaly, Schizencephaly 
SKI FMRP Shprintzen-Goldberg syndrome 
SLC4A10  Autism 
SMAD1  Brain Development 




SMARCA2 FMRP Nicolaides-Baraitser syndrome, Schizophrenia 
SMARCA4 FMRP Mental retardation, autosomal dominant 16 (ID) 
SMARCA5  Williams syndrome 
SMARCB1  Mental retardation, autosomal dominant 15 (ID) 
SMARCC1  Schizophrenia 
SMARCC2 FMRP  
SMURF2  Brain Development 
SND1  Autism 
SNIP1  Psychomotor retardation, epilepsy, and craniofacial dysmorphism 
SORBS2 FMRP  
SOX1  Brain Development 
SOX10  Waardenburg syndrome, Intellectual Disability 
SOX11  Brain Development 
SOX2  Brain Development 
SOX21  Brain Development 
SOX3  Intellectual Disability, Brain Development 
SOX4  Brain Development 
SOX5  Autism, Intellectual Disability, Brain Development 
SOX6  Brain Development 
SOX9  Brain Development 
SP1  Brain Development 
SP4  Schizophrenia 
SP8  Brain Development 
SPEN FMRP  
SRCAP  Floating-Harbor syndrome 




SREBF2 FMRP Schizophrenia 
SS18L1  Brain Development 
STAT6  Brain Development 
SUPT6H FMRP  
SUV420H1  Autism 
SUZ12  Brain Development 
TAF1  Dystonia-Parkinsonism, X-linked 
TAF1C  Autism 
TAF1L  Autism 
TAF2  Intellectual Disability 
TARDBP  Frontotemporal lobar degeneration, TARDBP-related 
TBL1X  Autism 
TBL1XR1  Autism 
TBP  Spinocerebellar ataxia 17, Schizophrenia 
TBR1  Autism, Brain Development 
TBX1  Autism, DiGeorge syndrome, Schizophrenia 
TCF20 FMRP  
TCF25 FMRP  
TCF4 FMRP Autism, Intellectual Disability, Pitt-Hopkins syndrome, Schizophrenia 
TCF7L2  Intellectual Disability 
TEF FMRP  
TFAM  Alzheimer's disease 
TFCP2  Alzheimer's disease 
TGFBR1  Brain Development 
TGIF1  Holoprosencephaly, Intellectual Disability 




THRB  Intellectual Disability 
TLE3 FMRP  
TNF  Alzheimer's disease, Parkinson disease 
TNRC18 FMRP  
TOP2B  Autism 
TP53  Alzheimer's disease 
TP63  Alzheimer's disease 
TP73  Alzheimer's disease 
TRAK1 FMRP Brain Development 
TRIM3 FMRP  
TRIM32 FMRP Bardet-Biedl syndrome 11 
TRIM33  Autism 
TRIM9 FMRP  
TRIP10  Huntington Disease 
TRMT1  Intellectual Disability 
TRPS1  Trichorhinophalangeal syndrome 
TRRAP FMRP  
TSC2 FMRP Intellectual Disability, Autism, Brain Development 
TSC22D1 FMRP  
TSHZ1 FMRP  
TSN  Autism 
TTF1  Intellectual Disability 
TTF2  Intellectual Disability 
TULP4 FMRP  
UBE2I  Alzheimer's disease 




UBE2L3  Parkinson's Disease 
UBE3A  Intellectual Disability, Autism, Angelman syndrome 
VHL  Brain Development 
WBP11  Renpenning syndrome 
WHSC1  Wolf-Hirschhorn syndrome 
WHSC1L1  Wolf-Hirschhorn syndrome 
WHSC2  Wolf-Hirschhorn syndrome 
WNT1  Autism, Osteogenesis impergecta with brain malformations 
WWOX  Spinocrebellar ataxia 
XBP1  Schizophrenia 
XPA  Intellectual Disability 
XPC  Autism 
YEATS2  Autism 
YY1  Intellectual Disability 
ZBED4  Schizophrenia 
ZBTB16  Autism 
ZBTB20  Brain Development 
ZBTB40  Intellectual Disability 
ZBTB45  Brain Development 
ZC3H14  Intellectual Disability 
ZC3H4 FMRP  
ZC3H7B FMRP  
ZDHHC15  Mental retardation, X-linked 91 (ID) 
ZDHHC9  Intellectual Disability, Mental retardation, X-linked syndromic, Raymond type 
ZEB2 FMRP Intellectual Disability, Mowat-Wilson syndrome 




ZFHX4  Chromosome 8q21.11 deletion syndrome 
ZFP106 FMRP  
ZFR FMRP  
ZFYVE26  Spastic paraplegia 15, autosomal recessive 
ZHX2  Brain Development 
ZHX3 FMRP  
ZIC1  Dandy-Walker syndrome 
ZIC2  Intellectual Disability, Holoprosencephaly 
ZIC3  VACTERL syndrome 
ZIC4  Dandy-Walker syndrome 
ZMIZ1 FMRP  
ZMIZ2 FMRP  
ZMYND11  Autism 
ZNF18  Autism 
ZNF238 FMRP  
ZNF292  Alzheimer's disease 
ZNF335  Microcephaly 10, primary, autosomal recessive 
ZNF365 FMRP  
ZNF384  Intellectual Disability 
ZNF385B  Autism, Chromosome 2q31.2 deletion syndrome 
ZNF395  Huntington Disease 
ZNF407  Autism 
ZNF41  Intellectual Disability, Mental retardation X-linked 
ZNF462 FMRP  
ZNF517  Autism 
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